Document:

<PAGE>
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

                             NEXTEL PARTNERS, INC.

                                  $200,000,000
                           11% Senior Notes due 2010
                               Purchase Agreement
                                 July 18, 2000

                          DONALDSON, LUFKIN & JENRETTE
                             SECURITIES CORPORATION
                         DEUTSCHE BANK SECURITIES INC.
                            CIBC WORLD MARKETS CORP.

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
<PAGE>
                                  $200,000,000
                           11% SENIOR NOTES DUE 2010
                            OF NEXTEL PARTNERS, INC.
                               PURCHASE AGREEMENT

                                                                   July 18, 2000

Donaldson, Lufkin & Jenrette Securities Corporation
Deutsche Bank Securities Inc.
CIBC World Markets Corp.
c/o Donaldson, Lufkin & Jenrette
Securities Corporation
277 Park Avenue
New York, New York 10172

Ladies and Gentlemen:

    Nextel Partners, Inc., a Delaware corporation (the "COMPANY"), proposes to
issue and sell to Donaldson, Lufkin & Jenrette Securities Corporation, ("DLJ"),
Deutsche Bank Securities Inc. and CIBC World Markets Corp. (each, an "INITIAL
PURCHASER" and, collectively, the "INITIAL PURCHASERS") an aggregate of
$200,000,000 in principal amount of its 11% Senior Notes due 2010 (the
"SERIES A NOTES"), subject to the terms and conditions set forth herein. The
Series A Notes are to be issued pursuant to the provisions of an indenture (the
"INDENTURE"), to be dated as of the Closing Date (as defined below), among the
Company and The Bank of New York, as trustee (the "TRUSTEE"). The Series A Notes
and the Series B Notes (as defined below) issuable in exchange therefor are
collectively referred to herein as the "NOTES." Capitalized terms used but not
defined herein shall have the meanings given to such terms in the Indenture.

    The Company intends to use the gross proceeds from the sale to the Initial
Purchasers of the Series A Notes for general corporate purposes, including to
fund the Network Build-out (as defined in the Offering Memorandum), operating
losses and working capital through 2003.

    1.  OFFERING MEMORANDUM. The Series A Notes will be offered and sold to the
Initial Purchasers pursuant to one or more exemptions from the registration
requirements under the Securities Act of 1933, as amended (the "ACT"). The
Company has prepared a final offering memorandum, dated July 18, 2000 (the
"OFFERING MEMORANDUM"), relating to the Series A Notes.

    Upon original issuance thereof, and until such time as the same is no longer
required pursuant to the Indenture, the Series A Notes (and all securities
issued in exchange therefor, in substitution thereof or upon conversion thereof)
shall bear the following legend:

        "THIS NOTE (OR ITS PREDECESSOR) HAS NOT BEEN REGISTERED UNDER THE U.S.
    SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY,
    MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHIN THE UNITED
    STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS, EXCEPT AS SET
    FORTH IN THE NEXT SENTENCE. BY ITS ACQUISITION HEREOF OR OF A BENEFICIAL
    INTEREST HEREIN, THE HOLDER:

       (1) REPRESENTS THAT (i) IT IS A "QUALIFIED INSTITUTIONAL BUYER" (AS
       DEFINED IN RULE 144A UNDER THE SECURITIES ACT) (A "QIB") OR (ii) IT HAS
       ACQUIRED THIS NOTE IN AN OFFSHORE TRANSACTION IN COMPLIANCE WITH
       REGULATION S UNDER THE ACT;

       (2) AGREES THAT IT WILL NOT RESELL OR OTHERWISE TRANSFER THIS NOTE EXCEPT
       (A) TO THE COMPANY OR ANY OF ITS SUBSIDIARIES, (B) TO A PERSON
<PAGE>
       WHOM THE SELLER REASONABLY BELIEVES IS A QIB PURCHASING FOR ITS OWN
       ACCOUNT OR FOR THE ACCOUNT OF A QIB IN A TRANSACTION MEETING THE
       REQUIREMENTS OF RULE 144A, (C) IN AN OFFSHORE TRANSACTION MEETING THE
       REQUIREMENTS OF RULE 903 OR 904 OF THE SECURITIES ACT, (D) IN A
       TRANSACTION MEETING THE REQUIREMENTS OF RULE 144 UNDER THE SECURITIES
       ACT, (E) TO AN INSTITUTIONAL "ACCREDITED INVESTOR" (AS DEFINED IN RULE
       501(A)(1), (2), (3) OR (7) OF REGULATION D UNDER THE SECURITIES ACT)
       THAT, PRIOR TO SUCH TRANSFER, FURNISHES THE TRUSTEE A SIGNED LETTER
       CONTAINING CERTAIN REPRESENTATIONS AND AGREEMENTS RELATING TO THE
       TRANSFER OF THIS NOTE (THE FORM OF WHICH CAN BE OBTAINED FROM THE
       TRUSTEE) AND, IF SUCH TRANSFER IS IN RESPECT OF AN AGGREGATE PRINCIPAL
       AMOUNT OF NOTES LESS THAN $250,000, AN OPINION OF COUNSEL ACCEPTABLE TO
       THE COMPANY THAT SUCH TRANSFER IS IN COMPLIANCE WITH THE SECURITIES ACT,
       (F) IN ACCORDANCE WITH ANOTHER EXEMPTION FROM THE REGISTRATION
       REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL
       ACCEPTABLE TO THE COMPANY) OR (G) PURSUANT TO AN EFFECTIVE REGISTRATION
       STATEMENT AND, IN EACH CASE, IN ACCORDANCE WITH THE APPLICABLE SECURITIES
       LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE
       JURISDICTION AND

       (3) AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THIS NOTE OR AN
       INTEREST HEREIN IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF
       THIS LEGEND.

    AS USED HEREIN, THE TERMS "OFFSHORE TRANSACTION" AND "UNITED STATES" HAVE
    THE MEANINGS GIVEN TO THEM BY RULE 902 OF REGULATION S UNDER THE SECURITIES
    ACT. THE INDENTURE CONTAINS A PROVISION REQUIRING THE TRUSTEE TO REFUSE TO
    REGISTER ANY TRANSFER OF THIS NOTE IN VIOLATION OF THE FOREGOING."

    2.  AGREEMENTS TO SELL AND PURCHASE.

    On the basis of the representations, warranties and covenants contained in
this Agreement, and subject to the terms and conditions contained herein, the
Company agrees to issue and sell to the Initial Purchasers, and each Initial
Purchaser agrees, severally and not jointly, to purchase from the Company, the
principal amounts of Series A Notes set forth opposite the name of such Initial
Purchaser on Schedule B hereto at a purchase price equal to 98.25% of the
principal amount thereof (the "PURCHASE PRICE").

    3.  TERMS OF OFFERING.

    The Initial Purchasers have advised the Company that the Initial Purchasers
will make offers (the "EXEMPT RESALES") of the Series A Notes purchased
hereunder on the terms set forth in the Offering Memorandum, as amended or
supplemented, solely to persons whom the Initial Purchasers reasonably believe
to be (i) "qualified institutional buyers" as defined in Rule 144A under the Act
("QIBS") and (ii) persons permitted to purchase the Series A Notes in offshore
transactions in reliance upon Regulation S under the Act (each, a "REGULATION S
PURCHASER") (such persons specified in this clause being referred to herein as
the "ELIGIBLE PURCHASERS"). The Initial Purchasers will offer the Series A Notes
to Eligible Purchasers initially at a price equal to 99.241% of the principal
amount thereof. Such price may be changed at any time without notice.

    Holders (including subsequent transferees) of the Series A Notes will have
the registration rights set forth in the registration rights agreement (the
"REGISTRATION RIGHTS AGREEMENT"), to be dated the Closing Date, in substantially
the form of Exhibit A hereto, for so long as such Series A Notes constitute
"TRANSFER RESTRICTED SECURITIES" (as defined in the Registration Rights
Agreement). Pursuant to the Registration Rights Agreement, the Company will
agree to file with the Securities and Exchange Commission (the

                                       2
<PAGE>
"COMMISSION") under the circumstances set forth therein, (i) a registration
statement under the Act (the "EXCHANGE OFFER REGISTRATION STATEMENT") relating
to the Company's 11% Series B Senior Notes due 2010 (the "SERIES B NOTES"), to
be offered in exchange for the Series A Notes (such offer to exchange being
referred to as the "EXCHANGE OFFER") and (ii) a shelf registration statement
pursuant to Rule 415 under the Act (the "SHELF REGISTRATION STATEMENT" and,
together with the Exchange Offer Registration Statement, the "REGISTRATION
STATEMENTS") relating to the resale by certain holders of the Series A Notes and
to use its best efforts to cause such Registration Statements to be declared and
remain effective and usable for the periods specified in the Registration Rights
Agreement and to consummate the Exchange Offer. This Agreement, the Indenture,
the Notes and the Registration Rights Agreement are hereinafter sometimes
referred to collectively as the "OPERATIVE DOCUMENTS."

    4.  DELIVERY AND PAYMENT.

    (a)  Delivery of, and payment of the Purchase Price for, the Series A Notes
shall be made at the offices of Latham & Watkins, 885 Third Avenue, Suite 1000,
New York, New York, 10022, or such other location as may be mutually acceptable.
Such delivery and payment shall be made at 9:00 a.m. New York City time, on or
before July 27, 2000 or at such other time on the same date or such other date
as shall be agreed upon by the Initial Purchasers and the Company in writing.
The time and date of such delivery and the payment for the Series A Notes are
herein called the "CLOSING DATE."

    (b)  One or more of the Series A Notes in definitive global form, registered
in the name of Cede & Co., as nominee of the Depository Trust Company ("DTC"),
having an aggregate principal amount corresponding to the aggregate principal
amount of the Series A Notes (collectively, the "GLOBAL NOTE"), shall be
delivered by the Company to the Initial Purchasers (or as the Initial Purchasers
direct) in each case with any transfer taxes thereon duly paid by the Company
against payment by the Initial Purchasers of the Purchase Price thereof by wire
transfer in immediately available funds to the order of the Company. The Global
Note shall be made available to the Initial Purchasers for inspection not later
than 9:30 a.m., New York City time, on the business day immediately preceding
the Closing Date.

    5.  AGREEMENTS OF THE COMPANY.

    The Company hereby agrees with the Initial Purchasers as follows:

        (a)  To advise the Initial Purchasers promptly and, if requested by the
    Initial Purchasers, confirm such advice in writing, (i) of the issuance by
    any state securities commission of any stop order suspending the
    qualification or exemption from qualification of any Series A Notes for
    offering or sale in any jurisdiction designated by the Initial Purchasers
    pursuant to Section 5(e) hereof, or the initiation of any proceeding by any
    state securities commission or any other federal or state regulatory
    authority for such purpose and (ii) of the happening of any event during the
    period referred to in Section 5(c) below that makes any statement of a
    material fact made in the Offering Memorandum untrue or that requires any
    additions to or changes in the Offering Memorandum in order to make the
    statements therein not misleading. The Company shall use all commercially
    reasonable efforts to prevent the issuance of any stop order or order
    suspending the qualification or exemption of any Series A Notes under any
    state securities or Blue Sky laws and, if at any time any state securities
    commission or other federal or state regulatory authority shall issue an
    order suspending the qualification or exemption of any Series A Notes under
    any state securities or Blue Sky laws, the Company shall use all
    commercially reasonable efforts to obtain the withdrawal or lifting of such
    order at the earliest possible time.

        (b)  To furnish the Initial Purchasers and those persons identified by
    the Initial Purchasers to the Company as many copies of the Offering
    Memorandum, and any amendments or supplements thereto, as the Initial
    Purchasers may reasonably request for the time period specified in
    Section 5(c). Subject to the Initial Purchasers' compliance with its
    representations and warranties and agreements set forth in Section 7 hereof,
    the Company consents to the use of the Offering Memorandum, and any

                                       3
<PAGE>
    amendments and supplements thereto required pursuant hereto, by the Initial
    Purchasers in connection with Exempt Resales.

        (c)  During such period as in the opinion of counsel for the Initial
    Purchasers an Offering Memorandum is required by law to be delivered in
    connection with Exempt Resales by the Initial Purchasers, (i) not to make
    any amendment or supplement to the Offering Memorandum of which the Initial
    Purchasers shall not previously have been advised or to which the Initial
    Purchasers shall reasonably object after being so advised and (ii) to
    prepare promptly upon the Initial Purchasers' reasonable request, any
    amendment or supplement to the Offering Memorandum which may be necessary or
    advisable in connection with such Exempt Resales.

        (d)  If, during the period referred to in Section 5(c) above, any event
    shall occur or condition shall exist as a result of which, in the opinion of
    counsel to the Initial Purchasers, it becomes necessary to amend or
    supplement the Offering Memorandum in order to make the statements therein,
    in the light of the circumstances when such Offering Memorandum is delivered
    to an Eligible Purchaser, not misleading, or if, in the opinion of counsel
    to the Initial Purchasers, it is necessary to amend or supplement the
    Offering Memorandum to comply with any applicable law, forthwith to prepare
    an appropriate amendment or supplement to such Offering Memorandum so that
    the statements therein, as so amended or supplemented, will not, in the
    light of the circumstances when it is so delivered, be misleading, or so
    that such Offering Memorandum will comply with applicable law, and to
    furnish to the Initial Purchasers and such other persons as the Initial
    Purchasers may designate such number of copies thereof as the Initial
    Purchasers may reasonably request.

        (e)  Prior to the sale of all Series A Notes pursuant to Exempt Resales
    as contemplated hereby, to cooperate with the Initial Purchasers and counsel
    to the Initial Purchasers in connection with the registration or
    qualification of the Series A Notes for offer and sale to the Initial
    Purchasers and pursuant to Exempt Resales under the securities or Blue Sky
    laws of such jurisdictions as the Initial Purchasers may request and to
    continue such registration or qualification in effect so long as required
    for Exempt Resales and to file such consents to service of process or other
    documents as may be necessary in order to effect such registration or
    qualification; PROVIDED, HOWEVER, that the Company shall not be required in
    connection therewith to qualify as a foreign corporation in any jurisdiction
    in which it is not now so qualified or to take any action that would subject
    it to general consent to service of process or taxation other than as to
    matters and transactions relating to the Offering Memorandum or Exempt
    Resales, in any jurisdiction in which it is not now so subject.

        (f)  So long as the Notes are outstanding, (i) to furnish as soon as
    practicable after the end of each fiscal year to the record holders of the
    Notes a financial report of the Company and its subsidiaries on a
    consolidated basis (and a similar financial report of all unconsolidated
    subsidiaries, if any), all such financial reports to include a consolidated
    balance sheet, a consolidated statement of operations, a consolidated
    statement of cash flows and a consolidated statement of shareholders' equity
    as of the end of and for such fiscal year, together with comparable
    information as of the end of and for the preceding year, certified by the
    Company's independent public accountants and (ii) to furnish as soon as
    practicable after the end of each quarterly period (except for the last
    quarterly period of each fiscal year) to such holders, a consolidated
    balance sheet, a consolidated statement of operations and a consolidated
    statement of cash flows (and similar financial reports of all unconsolidated
    subsidiaries, if any) as of the end of and for such period, and for the
    period from the beginning of such year to the close of such quarterly
    period, together with comparable information for the corresponding periods
    of the preceding year.

        (g)  So long as the Notes are outstanding, to furnish to the Initial
    Purchasers as soon as available copies of all reports or other
    communications furnished by the Company to its security holders or furnished
    to or filed with the Commission or any national securities exchange on which
    any class of securities of the Company is listed and such other publicly
    available information concerning the

                                       4
<PAGE>
    Company and/or its subsidiaries as the Initial Purchasers may reasonably
    request (without documents incorporated therein by reference or exhibits
    thereto, unless requested in writing).

        (h)  So long as any of the Series A Notes remain outstanding and during
    any period in which the Company is not subject to Section 13 or 15(d) of the
    Securities Exchange Act of 1934, as amended (the "EXCHANGE ACT"), to make
    available to any holder of Series A Notes in connection with any sale
    thereof and any prospective purchaser of such Series A Notes from such
    holder, the information ("RULE 144A INFORMATION") required by
    Rule 144A(d)(4) under the Act.

        (i)  Whether or not the transactions contemplated in this Agreement are
    consummated or this Agreement is terminated, to pay or cause to be paid all
    expenses incident to the performance of the obligations of the Company under
    this Agreement, including: (i) the fees, disbursements and expenses of
    counsel to the Company and accountants of the Company in connection with the
    sale and delivery of the Series A Notes to the Initial Purchasers and
    pursuant to Exempt Resales, and all other fees and expenses in connection
    with the preparation, printing, filing and distribution of the Offering
    Memorandum and all amendments and supplements to any of the foregoing
    (including financial statements), including the mailing and delivering of
    copies thereof to the Initial Purchasers and persons designated by the
    Initial Purchasers in the quantities specified herein, (ii) all costs and
    expenses related to the transfer and delivery of the Series A Notes to the
    Initial Purchasers and pursuant to Exempt Resales, including any transfer or
    other taxes payable thereon, (iii) all costs of printing or producing this
    Agreement, the other Operative Documents and any other agreements or
    documents in connection with the offering, purchase, sale or delivery of the
    Series A Notes, (iv) all expenses in connection with the registration or
    qualification of the Series A Notes for offer and sale under the securities
    or Blue Sky laws of the several states and all costs of printing or
    producing any preliminary and supplemental Blue Sky memoranda in connection
    therewith (including the filing fees and fees and disbursements of counsel
    for the Initial Purchasers in connection with such registration or
    qualification and memoranda relating thereto), (v) the cost of printing
    certificates representing the Series A Notes, (vi) all expenses and listing
    fees in connection with the application for quotation of the Series A Notes
    in the National Association of Securities Dealers, Inc. ("NASD") Automated
    Quotation System--PORTAL ("PORTAL"), (vii) the fees and expenses of the
    Trustee and the Trustee's counsel in connection with the Indenture and the
    Notes, (viii) the costs and charges of any transfer agent, registrar and/or
    depository (including DTC), (ix) any fees charged by rating agencies for the
    rating of the Notes, (x) all costs and expenses of the Exchange Offer and
    any Registration Statement, as set forth in the Registration Rights
    Agreement, and (xi) and all other costs and expenses incident to the
    performance of the obligations of the Company hereunder for which provision
    is not otherwise made in this Section, but excluding fees and expenses of
    counsel to the Initial Purchasers (other than fees and expenses set forth in
    clause (iv) above).

        (j)  To use all commercially reasonable efforts to effect the inclusion
    of the Series A Notes in PORTAL and to maintain the listing of the Series A
    Notes on PORTAL for so long as the Series A Notes are outstanding.

        (k)  To obtain the approval of DTC for "book-entry" transfer of the
    Notes, and to comply with all of its agreements set forth in the
    representation letters of the Company to DTC relating to the approval of the
    Notes by DTC for "book-entry" transfer.

        (l)  During the period beginning on the date hereof and continuing to
    and including the Closing Date, not to offer, sell, contract to sell or
    otherwise transfer or dispose of any debt securities of the Company or any
    warrants, rights or options to purchase or otherwise acquire debt securities
    of the Company substantially similar to the Notes (other than (i) the Notes
    and (ii) commercial paper issued in the ordinary course of business),
    without the prior written consent of the Initial Purchasers.

        (m)  Not to sell, offer for sale or solicit offers to buy or otherwise
    negotiate in respect of any security (as defined in the Act) that would be
    integrated with the sale of the Series A Notes to the

                                       5
<PAGE>
    Initial Purchasers or pursuant to Exempt Resales in a manner that would
    require the registration of any such sale of the Series A Notes under the
    Act.

        (n)  Not to voluntarily claim, and to actively resist any attempts to
    claim, the benefit of any usury laws against the holders of any Notes.

        (o)  To cause the Exchange Offer to be made in the appropriate form to
    permit Series B Notes registered pursuant to the Act to be offered in
    exchange for the Series A Notes and to comply with all applicable federal
    and state securities laws in connection with the Exchange Offer.

        (p)  To comply with all of its agreements set forth in the Registration
    Rights Agreement.

        (q)  To use all commercially reasonable efforts to do and perform all
    things required or necessary to be done and performed under this Agreement
    by it prior to the Closing Date and to satisfy all conditions precedent to
    the delivery of the Series A Notes.

    6.  REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE COMPANY.

    As of the date hereof, the Company represents and warrants to, and agrees
with, the Initial Purchasers that:

        (a)  The Offering Memorandum does not, and any supplement or amendment
    to it will not, contain any untrue statement of a material fact or omit to
    state any material fact required to be stated therein or necessary to make
    the statements therein, in the light of the circumstances under which they
    were made, not misleading, except that the representations and warranties
    contained in this paragraph (a) shall not apply to statements in or
    omissions from the Offering Memorandum (or any supplement or amendment
    thereto) based upon information relating to the Initial Purchasers furnished
    to the Company in writing by the Initial Purchasers expressly for use
    therein. No stop order preventing the use of the Offering Memorandum, or any
    amendment or supplement thereto, or any order asserting that any of the
    transactions contemplated by this Agreement are subject to the registration
    requirements of the Act, has been issued.

        (b)  Each of the Company and its subsidiaries has been duly
    incorporated, is validly existing as a corporation in good standing under
    the laws of its jurisdiction of incorporation and has the corporate power
    and authority to carry on its business as described in the Offering
    Memorandum and to own, lease and operate its properties, and each is duly
    qualified and is in good standing as a foreign corporation authorized to do
    business in each jurisdiction in which the nature of its business or its
    ownership or leasing of property requires such qualification, except where
    the failure to be so qualified would not have a material adverse effect on
    the business, prospects, financial condition or results of operations of the
    Company and its subsidiaries, taken as a whole (a "MATERIAL ADVERSE
    EFFECT").

        (c)  All outstanding shares of capital stock of the Company have been
    duly authorized and validly issued and are fully paid, non-assessable and,
    except for rights set forth in the Shareholders' Agreement and the Restated
    Certificate of Incorporation, are not subject to any preemptive or similar
    rights.

        (d)  The entities listed on Schedule A hereto are the only subsidiaries,
    direct or indirect, of the Company. All of the outstanding shares of capital
    stock of each of the Company's subsidiaries have been duly authorized and
    validly issued and are fully paid and non-assessable, and are owned by the
    Company, directly or indirectly through one or more subsidiaries, free and
    clear of any security interest, claim, lien, encumbrance or adverse interest
    of any nature (each, a "LIEN"), except for Liens (i) securing indebtedness
    under the Credit Facility and (ii) created by the Shareholders' Agreement
    and the Restated Certificate of Incorporation.

                                       6
<PAGE>
        (e)  This Agreement has been duly authorized, executed and delivered by
    the Company.

        (f)  The Indenture has been duly authorized by the Company and, on the
    Closing Date, will have been validly executed and delivered by the Company.
    When the Indenture has been duly executed and delivered by the Company, the
    Indenture will be a valid and binding agreement of the Company, enforceable
    against the Company in accordance with its terms except as (i) the
    enforceability thereof may be limited by bankruptcy, insolvency or similar
    laws affecting creditors' rights generally and (ii) rights of acceleration
    and the availability of equitable remedies may be limited by equitable
    principles of general applicability. On the Closing Date, the Indenture will
    conform in all material respects to the requirements of the Trust Indenture
    Act of 1939, as amended (the "TIA" or "TRUST INDENTURE ACT"), and the rules
    and regulations of the Commission applicable to an indenture which is
    qualified thereunder.

        (g)  The Series A Notes have been duly authorized and, on the Closing
    Date, will have been validly executed and delivered by the Company. When the
    Series A Notes have been issued, executed and authenticated in accordance
    with the provisions of the Indenture and delivered to and paid for by the
    Initial Purchasers in accordance with the terms of this Agreement, the
    Series A Notes will be entitled to the benefits of the Indenture and will be
    valid and binding obligations of the Company, enforceable in accordance with
    their terms except as (i) the enforceability thereof may be limited by
    bankruptcy, insolvency or similar laws affecting creditors' rights generally
    and (ii) rights of acceleration and the availability of equitable remedies
    may be limited by equitable principles of general applicability. On the
    Closing Date, the Series A Notes will conform as to legal matters to the
    description thereof contained in the Offering Memorandum.

        (h)  On the Closing Date, the Series B Notes will have been duly
    authorized by the Company. When the Series B Notes are issued, executed and
    authenticated in accordance with the terms of the Exchange Offer and the
    Indenture, the Series B Notes will be entitled to the benefits of the
    Indenture and will be the valid and binding obligations of the Company,
    enforceable against the Company in accordance with their terms, except as
    (i) the enforceability thereof may be limited by bankruptcy, insolvency or
    similar laws affecting creditors' rights generally and (ii) rights of
    acceleration and the availability of equitable remedies may be limited by
    equitable principles of general applicability.

        (i)  The Registration Rights Agreement has been duly authorized by the
    Company and, on the Closing Date, will have been duly executed and delivered
    by the Company. When the Registration Rights Agreement has been duly
    executed and delivered, the Registration Rights Agreement will be a valid
    and binding agreement of the Company, enforceable against the Company in
    accordance with its terms except as (i) the enforceability thereof may be
    limited by bankruptcy, insolvency or similar laws affecting creditors'
    rights generally and (ii) rights of acceleration and the availability of
    equitable remedies may be limited by equitable principles of general
    applicability. On the Closing Date, the Registration Rights Agreement will
    conform as to legal matters to the description thereof in the Offering
    Memorandum.

        (j)  Neither the Company nor any of its subsidiaries is in violation of
    its respective charter or by-laws or in default in the performance of any
    obligation, agreement, covenant or condition contained in any indenture,
    loan agreement, mortgage, lease or other agreement or instrument that is
    material to the Company and its subsidiaries, taken as a whole, to which the
    Company or any of its subsidiaries is a party or by which the Company or any
    of its subsidiaries or their respective property is bound.

        (k)  Except as disclosed in the Offering Memorandum, the execution,
    delivery and performance of this Agreement and the other Operative Documents
    by the Company, compliance by the Company with all provisions hereof and
    thereof and the consummation of the transactions contemplated hereby and
    thereby will not (i) require any consent, approval, authorization or other
    order of, or qualification with, any court or governmental body or agency
    (except such as may be required under the securities

                                       7
<PAGE>
    or Blue Sky laws of the various states), (ii) conflict with or constitute a
    breach of any of the terms or provisions of, or a default under, the charter
    or by-laws of the Company or any of its subsidiaries or any indenture, loan
    agreement, mortgage, lease or other agreement or instrument that is material
    to the Company and its subsidiaries, taken as a whole, to which the Company
    or any of its subsidiaries is a party or by which the Company or any of its
    subsidiaries or their respective property is bound, (iii) violate or
    conflict with any applicable law or any rule, regulation, judgment, order or
    decree of any court or any governmental body or agency having jurisdiction
    over the Company, any of its subsidiaries or their respective property,
    (iv) result in the imposition or creation of (or the obligation to create or
    impose) a Lien under, any agreement or instrument to which the Company or
    any of its subsidiaries is a party or by which the Company or any of its
    subsidiaries or their respective property is bound, or (v) result in the
    termination, suspension or revocation of any Authorization (as defined
    below) of the Company or any of its subsidiaries or result in any other
    impairment of the rights of the holder of any such Authorization.

        (l)  Except as disclosed in the Offering Memorandum, there are no legal
    or governmental proceedings pending or threatened to which the Company or
    any of its subsidiaries is or could be a party or to which any of their
    respective property is or could be subject, which would, if adversely
    determined, result, singly or in the aggregate, in a Material Adverse
    Effect.

        (m)  Neither the Company nor any of its subsidiaries has violated any
    foreign, federal, state or local law or regulation relating to the
    protection of human health and safety, the environment or hazardous or toxic
    substances or wastes, pollutants or contaminants ("ENVIRONMENTAL LAWS"), any
    provisions of the Employee Retirement Income Security Act of 1974, as
    amended ("ERISA"), or any provisions of the Foreign Corrupt Practices Act or
    the rules and regulations promulgated thereunder, except for such violations
    which, singly or in the aggregate, would not have a Material Adverse Effect.

        (n)  There are no costs or liabilities associated with Environmental
    Laws (including, without limitation, any capital or operating expenditures
    required for clean-up, closure of properties or compliance with
    Environmental Laws or any Authorization, any related constraints on
    operating activities and any potential liabilities to third parties) which
    would, singly or in the aggregate, have a Material Adverse Effect.

        (o)  Except as disclosed in the Offering Memorandum, each of the Company
    and its subsidiaries has such permits, licenses, consents, exemptions,
    franchises, authorizations and other approvals (each, an "AUTHORIZATION")
    of, and has made all filings with and notices to, all governmental or
    regulatory authorities and self-regulatory organizations and all courts and
    other tribunals, including without limitation, under any applicable
    Environmental Laws, as are necessary to own, lease, license and operate its
    respective properties and to conduct its business, except where the failure
    to have any such Authorization or to make any such filing or notice would
    not, singly or in the aggregate, have a Material Adverse Effect. Each such
    Authorization is valid and in full force and effect and each of the Company
    and its subsidiaries is in compliance with all the terms and conditions
    thereof and with the rules and regulations of the authorities and governing
    bodies having jurisdiction with respect thereto; and no event has occurred
    (including, without limitation, the receipt of any notice from any authority
    or governing body) which allows or, after notice or lapse of time or both,
    would allow, revocation, suspension or termination of any such Authorization
    or results or, after notice or lapse of time or both, would result in any
    other impairment of the rights of the holder of any such Authorization; and
    such Authorizations contain no restrictions that are burdensome to the
    Company or any of its subsidiaries; except where such failure to be valid
    and in full force and effect or to be in compliance, the occurrence of any
    such event or the presence of any such restriction would not, singly or in
    the aggregate, have a Material Adverse Effect.

        (p)  The PRO FORMA balance sheets included in the Offering Memorandum
    have been prepared in accordance with generally accepted accounting
    principles in the United States and give effect to assumptions used in the
    preparation thereof on a reasonable basis and in good faith and present
    fairly,

                                       8
<PAGE>
    in all material respects, the proposed transactions contemplated by the
    Offering Memorandum. The other PRO FORMA financial and statistical
    information and data included in the Offering Memorandum are, in all
    material respects, accurately presented and prepared on a basis consistent
    with the PRO FORMA balance sheet.

        (q)  The Company is not and, after giving effect to the offering and
    sale of the Series A Notes and the application of the net proceeds thereof
    as described in the Offering Memorandum, will not be, an "investment
    company," as such term is defined in the Investment Company Act of 1940, as
    amended.

        (r)  Other than the Amended and Restated Shareholders' Agreement (as
    defined in the Offering Memorandum), the Restated Certificate of
    Incorporation and the Registration Rights Agreement, there are no contracts,
    agreements or understandings between the Company and any person granting
    such person the right to require the Company to file a registration
    statement under the Act with respect to any securities of the Company or to
    require the Company to include such securities with the Notes registered
    pursuant to any Registration Statement.

        (s)  Neither the Company nor any of its subsidiaries nor any agent
    thereof acting on the behalf of them has taken, and none of them will take,
    any action that might cause this Agreement or the issuance or sale of the
    Series A Notes to violate Regulation T (12 C.F.R. Part 220), Regulation U
    (12 C.F.R. Part 221) or Regulation X (12 C.F.R. Part 224) of the Board of
    Governors of the Federal Reserve System.

        (t)  No "nationally recognized statistical rating organization" as such
    term is defined for purposes of Rule 436(g)(2) under the Act (i) has imposed
    (or has informed the Company that it is considering imposing) any condition
    (financial or otherwise) on the Company's retaining any rating assigned to
    the Company, any securities of the Company or (ii) has indicated to the
    Company that it is considering (a) the downgrading, suspension, or
    withdrawal of, or any review for a possible change that does not indicate
    the direction of the possible change in, any rating so assigned or (b) any
    change in the outlook for any rating of the Company, or any securities of
    the Company.

        (u)  Since the respective dates as of which information is given in the
    Offering Memorandum other than as set forth in the Offering Memorandum
    (exclusive of any amendments or supplements thereto subsequent to the date
    of this Agreement), (i) there has not occurred any material adverse change
    or any development involving a prospective material adverse change in the
    condition, financial or otherwise, or the earnings, business, management or
    operations of the Company and its subsidiaries, taken as a whole,
    (ii) there has not been any material adverse change or any development
    involving a prospective material adverse change in the capital stock or in
    the long-term debt of the Company or any of its subsidiaries and
    (iii) neither the Company nor any of its subsidiaries has incurred any
    material liability or obligation, direct or contingent.

        (v)  The Offering Memorandum, as of its date, contains all the
    information specified in, and meeting the requirements of, Rule 144A(d)(4)
    under the Act.

        (w)  When the Series A Notes are issued and delivered pursuant to this
    Agreement, the Series A Notes will not be of the same class (within the
    meaning of Rule 144A under the Act) as any security of the Company that is
    listed on a national securities exchange registered under Section 6 of the
    Exchange Act or that is quoted in a United States automated inter-dealer
    quotation system.

        (x)  No form of general solicitation or general advertising (as defined
    in Regulation D under the Act) was used by the Company or any of its
    respective representatives (other than the Initial Purchasers, as to whom
    the Company makes no representation) in connection with the offer and sale
    of the Series A Notes contemplated hereby, including, but not limited to,
    articles, notices or other communications published in any newspaper,
    magazine, or similar medium or broadcast over television or radio, or any
    seminar or meeting whose attendees have been invited by any general
    solicitation

                                       9
<PAGE>
    or general advertising. No securities of the same class as the Series A
    Notes have been issued and sold by the Company within the six-month period
    immediately prior to the date hereof.

        (y)  Prior to the effectiveness of any Registration Statement, the
    Indenture is not required to be qualified under the TIA.

        (z)  None of the Company or any of its affiliates, nor any person acting
    on its or their behalf (other than the Initial Purchasers, as to whom the
    Company makes no representation) has engaged or will engage in any directed
    selling efforts within the meaning of Regulation S under the Act
    ("REGULATION S") with respect to the Series A Notes.

        (aa) The Series A Notes offered and sold in reliance on Regulation S
    have been and will be offered and sold only in offshore transactions as
    defined in Rule 902 of Regulation S ("OFFSHORE TRANSACTIONS").

        (bb) The sale of the Series A Notes pursuant to Regulation S is not part
    of a plan or scheme to evade the registration provisions of the Act.

        (cc) The Company and its affiliates and all persons acting on their
    behalf (other than the Initial Purchasers, as to whom the Company makes no
    representation) have complied with and will comply with the offering
    restrictions requirements of Regulation S in connection with the offering of
    the Series A Notes outside the United States and, in connection therewith,
    the Offering Memorandum will contain the disclosure required by
    Rule 902(g)(2).

        (dd) The Company is a "reporting issuer" as defined in Rule 902 under
    the Act.

        (ee) No registration under the Act of the Series A Notes is required for
    the sale of the Series A Notes to the Initial Purchasers as contemplated
    hereby or for the Exempt Resales assuming the accuracy of the Initial
    Purchasers' representations and warranties and agreements set forth in
    Section 7 hereof.

        (ff) Each certificate signed by any officer of the Company and delivered
    to the Initial Purchasers or counsel for the Initial Purchasers shall be
    deemed to be a representation and warranty by the Company to the Initial
    Purchasers as to the matters covered thereby.

        The Company acknowledges that the Initial Purchasers and, for purposes
    of the opinions to be delivered to the Initial Purchasers pursuant to
    Section 9 hereof, counsel to the Company and counsel to the Initial
    Purchasers will rely upon the accuracy and truth of the foregoing
    representations and hereby consents to such reliance.

    7.  INITIAL PURCHASERS' REPRESENTATIONS AND WARRANTIES.

    Each of the Initial Purchasers, severally and not jointly, represents and
warrants to the Company, and agrees that:

        (a)  Such Initial Purchaser is a QIB with such knowledge and experience
    in financial and business matters as is necessary in order to evaluate the
    merits and risks of an investment in the Series A Notes.

        (b)  Such Initial Purchaser (A) is not acquiring the Series A Notes with
    a view to any distribution thereof or with any present intention of offering
    or selling any of the Series A Notes in a transaction that would violate the
    Act or the securities laws of any state of the United States or any other
    applicable jurisdiction and (B) will be reoffering and reselling the
    Series A Notes only to (x) QIBs in reliance on the exemption from the
    registration requirements of the Act provided by Rule 144A and (y) in
    Offshore Transactions in reliance upon Regulation S under the Act.

        (c)  Such Initial Purchaser agrees that no form of general solicitation
    or general advertising (within the meaning of Regulation D under the Act)
    has been or will be used by such Initial Purchaser or any of its
    representatives in connection with the offer and sale of the Series A Notes
    pursuant

                                       10
<PAGE>
    hereto, including, but not limited to, articles, notices or other
    communications published in any newspaper, magazine or similar medium or
    broadcast over television or radio, or any seminar or meeting whose
    attendees have been invited by any general solicitation or general
    advertising.

        (d)  Such Initial Purchaser agrees that, in connection with Exempt
    Resales, such Initial Purchaser will solicit offers to buy the Series A
    Notes only from, and will offer to sell the Series A Notes only to, Eligible
    Purchasers. Each Initial Purchaser further agrees that it will offer to sell
    the Series A Notes only to, and will solicit offers to buy the Series A
    Notes only from Eligible Purchasers that such Initial Purchaser reasonably
    believes are QIBs, and Regulation S Purchasers, in each case, that agree
    that (x) the Series A Notes purchased by them may be resold, pledged or
    otherwise transferred within the time period referred to under Rule 144(k)
    (taking into account the provisions of Rule 144(d) under the Act, if
    applicable) under the Act, as in effect on the date of the transfer of such
    Series A Notes, only (I) to the Company or any of its subsidiaries, (II) to
    a person whom the seller reasonably believes is a QIB purchasing for its own
    account or for the account of a QIB in a transaction meeting the
    requirements of Rule 144A under the Act, (III) in an Offshore Transaction
    meeting the requirements of Rule 904 of the Act, (IV) in a transaction
    meeting the requirements of Rule 144 under the Act, (V) to an Accredited
    Institution that, prior to such transfer, furnishes the Trustee a signed
    letter containing certain representations and agreements relating to the
    registration of transfer of such Series A Note (the form of which may be
    obtained from the Trustee) and, if such transfer is in respect of an
    aggregate principal amount of Series A Notes less than $250,000, an opinion
    of counsel acceptable to the Company that such transfer is in compliance
    with the Act, (VI) in accordance with another exemption from the
    registration requirements of the Act (and based upon an opinion of counsel
    acceptable to the Company) or (VII) pursuant to an effective registration
    statement and, in each case, in accordance with the applicable securities
    laws of any state of the United States or any other applicable jurisdiction
    and (y) they will deliver to each person to whom such Series A Notes or an
    interest therein is transferred a notice substantially to the effect of the
    foregoing.

        (e)  Such Initial Purchaser and its affiliates or any person acting on
    its or their behalf have not engaged or will not engage in any directed
    selling efforts within the meaning of Regulation S with respect to the
    Series A Notes.

        (f)  The Series A Notes offered and sold by such Initial Purchaser
    pursuant hereto in reliance on Regulation S have been and will be offered
    and sold only in Offshore Transactions.

        (g)  The sale of the Series A Notes offered and sold by such Initial
    Purchaser pursuant hereto in reliance on Regulation S is not part of a plan
    or scheme to evade the registration provisions of the Act.

        (h)  Such Initial Purchaser agrees that it has not offered or sold and
    will not offer or sell the Series A Notes in the United States or to, or for
    the benefit or account of, a U.S. Person (other than a distributor), in each
    case, as defined in Rule 902 under the Act (i) as part of its distribution
    at any time and (ii) otherwise until 40 days after the later of the
    commencement of the offering of the Series A Notes pursuant hereto and the
    Closing Date, other than in accordance with Regulation S of the Act or
    another exemption from the registration requirements of the Act. Such
    Initial Purchaser agrees that, during such 40-day distribution compliance
    period, it will not cause any advertisement with respect to the Series A
    Notes (including any "tombstone" advertisement) to be published in any
    newspaper or periodical or posted in any public place and will not issue any
    circular relating to the Series A Notes, except such advertisements as are
    permitted by and include the statements required by Regulation S.

        (i)  Such Initial Purchaser agrees that, at or prior to confirmation of
    a sale of Series A Notes by it to any distributor, dealer or person
    receiving a selling concession, fee or other remuneration during the 40-day
    distribution compliance period referred to in Rule 903(c)(2) under the Act,
    it will send to

                                       11
<PAGE>
    such distributor, dealer or person receiving a selling concession, fee or
    other remuneration a confirmation or notice to substantially the following
    effect:

           "The Series A Notes covered hereby have not been registered under the
       U.S. Securities Act of 1933, as amended (the "Securities Act"), and may
       not be offered and sold within the United States or to, or for the
       account or benefit of, U.S. persons (i) as part of your distribution at
       any time or (ii) otherwise until 40 days after the later of the
       commencement of the Offering and the Closing Date, except in either case
       in accordance with Regulation S under the Securities Act (or Rule 144A or
       to Accredited Institutions in transactions that are exempt from the
       registration requirements of the Securities Act), and in connection with
       any subsequent sale by you of the Series A Notes covered hereby in
       reliance on Regulation S during the period referred to above to any
       distributor, dealer or person receiving a selling concession, fee or
       other remuneration, you must deliver a notice to substantially the
       foregoing effect. Terms used above have the meanings assigned to them in
       Regulation S."

    Such Initial Purchaser acknowledges that the Company and, for purposes of
the opinions to be delivered to such Initial Purchaser pursuant to Section 9
hereof, counsel to the Company and counsel to the Initial Purchasers will rely
upon the accuracy and truth of the foregoing representations and such Initial
Purchaser hereby consents to such reliance.

    8.  INDEMNIFICATION.

    (a)  The Company agrees to indemnify and hold harmless each Initial
Purchaser, its directors, its officers and each person, if any, who controls
such Initial Purchaser within the meaning of Section 15 of the Act or
Section 20 of the Exchange Act, from and against any and all losses, claims,
damages, liabilities and judgments (including, without limitation, any legal or
other expenses incurred in connection with investigating or defending any
matter, including any action, that could give rise to any such losses, claims,
damages, liabilities or judgments) caused by any untrue statement or alleged
untrue statement of a material fact contained in the Offering Memorandum (or any
amendment or supplement thereto) or any Rule 144A Information provided by the
Company to any holder or prospective purchaser of Series A Notes pursuant to
Section 5(h) or caused by any omission or alleged omission to state therein a
material fact required to be stated therein or necessary to make the statements
therein not misleading, except insofar as such losses, claims, damages,
liabilities or judgments are caused by any such untrue statement or omission or
alleged untrue statement or omission based upon information relating to such
Initial Purchaser furnished in writing to the Company by such Initial
Purchasers.

    (b)  Each Initial Purchaser, severally and not jointly, agrees to indemnify
and hold harmless the Company, and its directors and officers and each person,
if any, who controls (within the meaning of Section 15 of the Act or Section 20
of the Exchange Act) the Company, to the same extent as the foregoing indemnity
from the Company to the Initial Purchasers but only with reference to
information relating to such Initial Purchaser furnished in writing to the
Company by such Initial Purchaser expressly for use in the Offering Memorandum,
and not with respect to the information provided by any other Initial Purchaser.

    (c)  In case any action shall be commenced involving any person in respect
of which indemnity may be sought pursuant to Section 8(a) or 8(b) (the
"INDEMNIFIED PARTY"), the indemnified party shall promptly notify the person
against whom such indemnity may be sought (the "INDEMNIFYING PARTY") in writing
and the indemnifying party shall assume the defense of such action, including
the employment of counsel reasonably satisfactory to the indemnified party and
the payment of all fees and expenses of such counsel, as incurred (except that
in the case of any action in respect of which indemnity may be sought pursuant
to both Sections 8(a) and 8(b), the Initial Purchasers shall not be required to
assume the defense of such action pursuant to this Section 8(c), but may employ
separate counsel and participate in the defense thereof, but the fees and
expenses of such counsel, except as provided below, shall be at the expense of
the Initial Purchasers). Any indemnified party shall have the right to employ
separate counsel in any such

                                       12
<PAGE>
action and participate in the defense thereof, but the fees and expenses of such
counsel shall be at the expense of the indemnified party unless (i) the
employment of such counsel shall have been specifically authorized in writing by
the indemnifying party, (ii) the indemnifying party shall have failed to assume
the defense of such action or employ counsel reasonably satisfactory to the
indemnified party or (iii) the named parties to any such action (including any
impleaded parties) include both the indemnified party and the indemnifying
party, and the indemnified party shall have been advised by such counsel that
there may be one or more legal defenses available to it which are different from
or additional to those available to the indemnifying party (in which case the
indemnifying party shall not have the right to assume the defense of such action
on behalf of the indemnified party). In any such case, the indemnifying party
shall not, in connection with any one action or separate but substantially
similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances, be liable for the fees and expenses of
more than one separate firm of attorneys (in addition to any local counsel) for
all indemnified parties and all such fees and expenses shall be reimbursed as
they are incurred. Such firm shall be designated in writing by Donaldson,
Lufkin & Jenrette Securities Corporation, in the case of the parties indemnified
pursuant to Section 8(a), and by the Company, in the case of parties indemnified
pursuant to Section 8(b). The indemnifying party shall indemnify and hold
harmless the indemnified party from and against any and all losses, claims,
damages, liabilities and judgments by reason of any settlement of any action
(i) effected with its written consent or (ii) effected without its written
consent if the settlement is entered into more than twenty business days after
the indemnifying party shall have received a request from the indemnified party
for reimbursement for the fees and expenses of counsel (in any case where such
fees and expenses are at the expense of the indemnifying party) and, prior to
the date of such settlement, the indemnifying party shall have failed to comply
with such reimbursement request. No indemnifying party shall, without the prior
written consent of the indemnified party, effect any settlement or compromise
of, or consent to the entry of judgment with respect to, any pending or
threatened action in respect of which the indemnified party is or could have
been a party and indemnity or contribution may be or could have been sought
hereunder by the indemnified party, unless such settlement, compromise or
judgment (i) includes an unconditional release of the indemnified party from all
liability on claims that are or could have been the subject matter of such
action and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act, by or on behalf of the indemnified party.

    (d)  To the extent the indemnification provided for in this Section 8 is
unavailable to an indemnified party or insufficient in respect of any losses,
claims, damages, liabilities or judgments referred to therein, then each
indemnifying party, in lieu of indemnifying such indemnified party, shall
contribute to the amount paid or payable by such indemnified party as a result
of such losses, claims, damages, liabilities and judgments (i) in such
proportion as is appropriate to reflect the relative benefits received by the
Company, on the one hand, and the Initial Purchasers on the other hand from the
offering of the Series A Notes or (ii) if the allocation provided by
clause 8(d)(i) above is not permitted by applicable law, in such proportion as
is appropriate to reflect not only the relative benefits referred to in
clause 8(d)(i) above but also the relative fault of the Company, on the one
hand, and the Initial Purchasers, on the other hand, in connection with the
statements or omissions which resulted in such losses, claims, damages,
liabilities or judgments, as well as any other relevant equitable
considerations. The relative benefits received by the Company, on the one hand
and the Initial Purchasers, on the other hand, shall be deemed to be in the same
proportion as the total net proceeds from the offering of the Series A Notes
(after underwriting discounts and commissions, but before deducting expenses)
received by the Company, and the total discounts and commissions received by the
Initial Purchasers bear to the total price to investors of the Series A Notes,
in each case as set forth in the table on the cover page of the Offering
Memorandum. The relative fault of the Company, on the one hand, and the Initial
Purchasers, on the other hand, shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the
omission or alleged omission to state a material fact relates to information
supplied by the Company, on the one hand, or the Initial Purchasers, on the
other hand, and the parties' relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission.

                                       13
<PAGE>
    The Company and the Initial Purchasers agree that it would not be just and
equitable if contribution pursuant to this Section 8(d) were determined by pro
rata allocation (even if the Initial Purchasers were treated as one entity for
such purpose) or by any other method of allocation which does not take account
of the equitable considerations referred to in the immediately preceding
paragraph. The amount paid or payable by an indemnified party as a result of the
losses, claims, damages, liabilities or judgments referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses incurred by such indemnified party in
connection with investigating or defending any matter, including any action,
that could have given rise to such losses, claims, damages, liabilities or
judgments. Notwithstanding the provisions of this Section 8, the Initial
Purchasers shall not be required to contribute any amount in excess of the
amount by which the total discounts and commissions received by such Initial
Purchasers exceeds the amount of any damages which such Initial Purchasers has
otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Initial Purchasers' obligations to contribute pursuant to
this Section 8(d) are several in proportion to the respective principal amount
of Series A Notes purchased by each of the Initial Purchasers hereunder and not
joint.

    (e)  The remedies provided for in this Section 8 are not exclusive and shall
not limit any rights or remedies which may otherwise be available to any
indemnified party at law or in equity.

    9.  CONDITIONS OF INITIAL PURCHASERS' OBLIGATIONS.

    The obligations of the Initial Purchasers to purchase the Series A Notes
under this Agreement are subject to the satisfaction of each of the following
conditions:

    (a)  All the representations and warranties of the Company contained in this
Agreement shall be true and correct on the Closing Date with the same force and
effect as if made on and as of the Closing Date.

    (b)  On or after the date hereof, (i) there shall not have occurred any
downgrading, suspension or withdrawal of, nor shall any notice have been given
of any potential or intended downgrading, suspension or withdrawal of, or of any
review (or of any potential or intended review) for a possible change that does
not indicate the direction of the possible change in, any rating of the Company
or any securities of the Company (including, without limitation, the placing of
any of the foregoing ratings on credit watch with negative or developing
implications or under review with an uncertain direction) by any "nationally
recognized statistical rating organization" as such term is defined for purposes
of Rule 436(g)(2) under the Act, (ii) there shall not have occurred any change,
nor shall any notice have been given of any potential or intended change, in the
outlook for any rating of the Company or any securities of the Company by any
such rating organization and (iii) no such rating organization shall have given
notice that it has assigned (or is considering assigning) a lower rating to the
Notes than that on which the Notes were marketed.

    (c)  Since the respective dates as of which information is given in the
Offering Memorandum, other than as set forth in the Offering Memorandum
(exclusive of any amendments or supplements thereto subsequent to the date of
this Agreement), (i) there shall not have occurred any change or any development
involving a prospective change in the condition, financial or otherwise, or the
earnings, business, management or operations of the Company and its
subsidiaries, taken as a whole, (ii) there shall not have been any change or any
development involving a prospective change in the capital stock or in the
long-term debt of the Company or any of its subsidiaries and (iii) neither the
Company nor any of its subsidiaries shall have incurred any liability or
obligation, direct or contingent, the effect of which, in any such case
described in clause 9(c)(i), 9(c)(ii) or 9(c)(iii), in DLJ's reasonable
judgment, is material and adverse and, in DLJ's reasonable judgment, makes it
impracticable to market the Series A Notes on the terms and in the manner
contemplated in the Offering Memorandum.

                                       14
<PAGE>
        (d)  You shall have received on the Closing Date a certificate dated the
    Closing Date, signed by the President and the Chief Financial Officer of the
    Company, confirming the matters set forth in Sections 9(a), 9(b) and 9(c)
    and stating that the Company has complied with all the agreements and
    satisfied all of the conditions herein contained and required to be complied
    with or satisfied on or prior to the Closing Date.

        (e)  You shall have received on the Closing Date an opinion
    (satisfactory to you and counsel for the Initial Purchasers), dated the
    Closing Date, of Summit Law Group, PLLC, special counsel for the Company
    substantially to the effect that:

           (i)  each of the Company and its subsidiaries has been duly
       incorporated, is validly existing as a corporation in good standing under
       the laws of its jurisdiction of incorporation and has the corporate power
       and authority to carry on its business as described in the Offering
       Memorandum and to own, lease and operate its properties;

           (ii)  each of the Company and its subsidiaries (as set forth on
       Schedule A hereto) is duly qualified and is in good standing as a foreign
       corporation authorized to do business in each jurisdiction in which the
       nature of its business or its ownership or leasing of property requires
       such qualification, except where the failure to be so qualified would not
       have a Material Adverse Effect;

           (iii)  all the outstanding shares of capital stock of the Company as
       set forth in the Offering Memorandum have been duly authorized and
       validly issued and are fully paid, non-assessable and, to our knowledge,
       not subject to any preemptive or similar rights except as provided in the
       Restated Certificate of Incorporation or the Amended and Restated
       Shareholders' Agreement;

           (iv)  all of the outstanding shares of capital stock of each of the
       Company's subsidiaries have been duly authorized and validly issued and
       are fully paid and non-assessable, and, to the best of such counsel's
       knowledge, are owned by the Company, free and clear of any Lien other
       than pursuant to (A) the Credit Facility, (B) the Restated Certificate of
       Incorporation or (C) the Amended and Restated Shareholders' Agreement;

           (v)  the Series A Notes have been duly authorized and, when executed
       and authenticated in accordance with the provisions of the Indenture and
       delivered to and paid for by the Initial Purchasers in accordance with
       the terms of this Agreement, will be entitled to the benefits of the
       Indenture and will be valid and binding obligations of the Company,
       enforceable in accordance with their terms except as (x) the
       enforceability thereof may be limited by bankruptcy, insolvency or
       similar laws affecting creditors' rights generally and (y) rights of
       acceleration and the availability of equitable remedies may be limited by
       equitable principles of general applicability;

           (vi)  the Indenture has been duly authorized, executed and delivered
       by the Company and is a valid and binding agreement of the Company,
       enforceable against the Company in accordance with its terms except as
       (x) the enforceability thereof may be limited by bankruptcy, insolvency
       or similar laws affecting creditors' rights generally and (y) rights of
       acceleration and the availability of equitable remedies may be limited by
       equitable principles of general applicability;

           (vii)  this Agreement has been duly authorized, executed and
       delivered by the Company;

           (viii)  The Registration Rights Agreement has been duly authorized,
       executed and delivered by the Company and is a valid and binding
       agreement of the Company, enforceable against the Company in accordance
       with its terms, except as (x) the enforceability thereof may be limited
       by bankruptcy, insolvency or similar laws affecting creditors' rights
       generally, (y) rights of acceleration and the availability of equitable
       remedies may be limited by equitable principles of general applicability
       and (z) indemnity provisions may be unenforceable as against public
       policy;

           (ix)  the Series B Senior Notes have been duly authorized;

                                       15
<PAGE>
           (x)  the statements under the captions "Business," "Description of
       Notes" (to the extent that they constitute a summary of the terms of the
       Notes) and "Related-Party Transactions" (to the extent that they
       constitute a summary of the documents referred to therein and subject to
       the qualification that reference is made to the Agreements and the
       Restated Certificate of Incorporation referred to therein for a full
       description of the matters contained therein) in the Offering Memorandum,
       in each case accurately summarizes the legal matters purported to be
       summarized therein;

           (xi)  the statements in the Offering Memorandum under the caption
       "Certain United States Federal Income Tax Consequences," to the extent
       they constitute matters of United States law or legal conclusions with
       respect thereto, have been prepared or reviewed by us and are correct in
       all material respects and accurately summarize the matters set forth
       therein;

           (xii)  Except for the post-closing authorizations and approvals
       referred to in the Offering Memorandum, the execution, delivery and
       performance of this Agreement and the other Operative Documents by the
       Company, the compliance by the Company with all provisions hereof and
       thereof and the consummation of the transactions contemplated hereby and
       thereby will not (i) require any consent, approval, authorization or
       other order of, or qualification with, any court or governmental body or
       agency (except such as may be required under the securities or Blue Sky
       laws of the various states), (ii) conflict with or constitute a breach of
       any of the terms or provisions of, or a default under, the charter or
       by-laws of the Company or any of its subsidiaries or, to the knowledge of
       counsel, any indenture, loan agreement, mortgage, lease or other
       agreement or instrument that is material to the Company and its
       subsidiaries, taken as a whole, to which the Company or any of its
       subsidiaries is a party or by which the Company or any of its
       subsidiaries or their respective property is bound, (iii) violate or
       conflict with any applicable law or any rule or regulation, or, to the
       knowledge of counsel, any judgment, order or decree of any court or any
       governmental body or agency having jurisdiction over the Company, any of
       its subsidiaries or their respective property, (iv) to the knowledge of
       counsel, result in the imposition or creation of (or the obligation to
       create or impose) a Lien under, any agreement or instrument to which the
       Company or any of its subsidiaries is a party or by which the Company or
       any of its subsidiaries or their respective property is bound, or (v) to
       the knowledge of counsel, result in the termination, suspension or
       revocation of any Authorization (as defined above) of the Company or any
       of its subsidiaries or result in any other impairment of the rights of
       the holder of any such Authorization except as enforcement of rights to
       indemnity or contribution may be limited by Federal or state securities
       laws or principles of public policy;

           (xiii)  the Company is not and, after giving effect to the offering
       and sale of the Series A Notes and the application of the net proceeds
       thereof as described in the Offering Memorandum, will not be, an
       "investment company" as such term is defined in the Investment Company
       Act of 1940, as amended;

           (xiv)  the Indenture complies as to form in all material respects
       with the requirements of the TIA, and the rules and regulations of the
       Commission applicable to an indenture which is qualified thereunder. It
       is not necessary in connection with the offer, sale and delivery of the
       Series A Notes to the Initial Purchaser in the manner contemplated by
       this Agreement or in connection with the Exempt Resales to qualify the
       Indenture under the TIA; and

           (xv)  no registration under the Act of the Series A Notes is required
       for the sale of the Series A Notes to the Initial Purchasers as
       contemplated by this Agreement or for the Exempt Resales assuming that
       (i) each Initial Purchaser is a QIB or a Regulation S Purchaser,
       (ii) the accuracy of, and compliance with, the Initial Purchasers'
       representations and agreements contained in Section 7 of this Agreement,
       (iii) the accuracy of the representations of the Company set forth in
       Sections 6(v), (w) and (x) of this Agreement.

                                       16
<PAGE>
    Nothing has come to the attention of such counsel that has led them to
believe that, as of the date of the Offering Memorandum or as of the Closing
Date, the Offering Memorandum, as amended or supplemented, if applicable (except
for the financial data included therein (including the supporting notes), as to
which such counsel does not express any belief) contains any untrue statement of
a material fact or omits to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were
made, not misleading.

    The statement of Summit Law Group, PLLC, in the penultimate paragraph of
this Section 9(e) shall be rendered to you at the request of the Company and
shall so state therein. In providing such statement with respect to the matters
covered by the penultimate paragraph of this Section 9(e), Summit Law Group,
PLLC, may state that their statement is based upon their participation in the
preparation of the Offering Memorandum and any amendments or supplements thereto
and review and discussion of the contents thereof, but is without independent
check or verification except as specified.

        (f)  You shall have received on the Closing Date an opinion
    (satisfactory to you and counsel for the Initial Purchasers), dated the
    Closing Date, of Willkie Farr & Gallagher, special FCC counsel for the
    Company, to the effect that:

           (i)  The execution and delivery by the Company of, and the
       performance by the Company of its obligations under, this Agreement and
       any other agreement executed in connection with the transactions
       contemplated thereby do not violate (i) the Federal Communications Act of
       1934, as amended (the "Communications Act"), (ii) any rules or
       regulations of the Federal Communications Commission ("FCC") applicable
       to the Company, or (iii) to the best of such counsel's knowledge, any
       decree from any court or tribunal, and (B) no authorization of or filing
       with the FCC is necessary for the execution and delivery of or the
       performance by the Company of its obligations under this Agreement or any
       other agreement executed in connection with the transactions contemplated
       thereby in accordance with the terms thereof, except such as have been
       obtained;

           (ii)  To the best of such counsel's knowledge, (A) The Company and
       its subsidiaries have all certificates, orders, permits, licenses,
       authorizations, consents and approvals of and from, and have made all
       reports, filings and registrations with, and paid all fees required by,
       the FCC necessary to own, lease, license and use its properties and
       assets and to conduct its business in the manner described in the
       Offering Memorandum, except where such failure would not materially
       affect their business operations as a whole; and (B) the Company and each
       subsidiary have not received any notice of proceedings relating to the
       violation, revocation or modification of any such certificates, orders,
       permits, licenses, authorizations, consents or approvals, or the
       qualifications or rejection of any such filing or registration, the
       effect of which, singly or in the aggregate, would have a Material
       Adverse Effect on the business or operations of the Company and its
       subsidiaries, taken as a whole;

           (iii)  To the best of such counsel's knowledge, each of the Company
       and any of its subsidiaries is not in violation of, or in default under,
       the Communications Act or the telecommunications rules or regulations of
       the FCC, the effect of which, singly or in the aggregate, would have a
       Material Adverse Effect on the Company and it subsidiaries, taken as a
       whole;

           (iv)  To the best of such counsel's knowledge (A) no adverse
       judgment, decree or order of the FCC has been issued against the Company
       or any of its subsidiaries and (B) no litigation, proceeding inquiry or
       investigation has been commenced or threatened against the Company or any
       of its subsidiaries before or by the FCC which, if decided adversely to
       its interest, would have a Material Adverse Effect on the Company and its
       subsidiaries, taken as a whole; and

           (v)  The statements set forth in the Offering Memorandum under
       captions "Risk Factors--Risk Factors Relating To Our Industry--Regulatory
       authorities exercise considerable power over

                                       17
<PAGE>
       our operations, which could be exercised against our interests and impose
       additional unanticipated costs" and "Regulation", insofar as they purport
       to describe the provisions of the laws and documents referred to therein,
       are accurate, complete and fair;

    Nothing has come to the attention of such counsel that has led them to
believe that, as of the date of the Offering Memorandum or as of the Closing
Date, the Offering Memorandum, as amended or supplemented, if applicable (except
for the financial statements and other financial data included therein
(including the supporting notes), as to which such counsel does not express any
belief) contains any untrue statement of a material fact or omits to state a
material fact necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading.

    The statement of Willkie Farr & Gallagher in the penultimate paragraph of
this Section 9(f) shall be rendered to you at the request of the Company and
shall so state therein. In providing such statement with respect to the matters
covered by the penultimate paragraph of this Section 9(f), Willkie Farr &
Gallagher may state that their statement is based upon their participation in
the preparation of the Offering Memorandum and any amendments or supplements
thereto and review and discussion of the contents thereof, but is without
independent check or verification except as specified.

        (g)  You shall have received on the Closing Date an opinion
    (satisfactory to you and counsel for the Initial Purchasers), dated the
    Closing Date, of Donald Manning, Esq., general counsel of the Company, to
    the effect that:

           (i)  each of the Company and its subsidiaries has such Authorizations
       of, and has made all filings with and notices to, all governmental or
       regulatory authorities and self-regulatory organizations and all courts
       and other tribunals, including without limitation, under any applicable
       Environmental Laws, as are necessary to own, lease, license and operate
       its respective properties and to conduct its business, except where the
       failure to have any such Authorization or to make any such filing or
       notice would not reasonably be expected to, singly or in the aggregate,
       have a Material Adverse Effect and except for such matters as are
       disclosed in the Offering Memorandum. Each such Authorization is valid
       and in full force and effect and each of the Company and its subsidiaries
       is in compliance with all the terms and conditions thereof and with the
       rules and regulations of the authorities and governing bodies having
       jurisdiction with respect thereto; and to the best of such counsel's
       knowledge, no event has occurred (including the receipt of any notice
       from any authority or governing body) which allows or, after notice or
       lapse of time or both, would allow, revocation, suspension or termination
       of any such Authorization or results or, after notice or lapse of time or
       both, would result in any other impairment of the rights of the holder of
       any such Authorization; except where such failure to be valid and in full
       force and effect or to be in compliance or the occurrence of any such
       event would not reasonably be expected to, singly or in the aggregate,
       have a Material Adverse Effect and except for such matters as are
       disclosed in the Offering Memorandum;

           (ii)  neither the Company nor any of its subsidiaries is in violation
       of its respective charter or by-laws and, to the best of such counsel's
       knowledge after due inquiry, neither the Company nor any of its
       subsidiaries is in default in the performance of any obligation,
       agreement, covenant or condition contained in any indenture, loan
       agreement, mortgage, lease or other agreement or instrument that is
       material to the Company and its subsidiaries, taken as a whole, to which
       the Company or any of its subsidiaries is a party or by which the Company
       or any of its subsidiaries or their respective property is bound;

           (iii)  to the best of such counsel's knowledge after due inquiry
       other than the Amended and Restated Shareholders' Agreement and the
       Restated Certificate of Incorporation, there are no contracts, agreements
       or understandings between the Company and any person granting such person
       the right to require the Company to file a registration statement under
       the Act with

                                       18
<PAGE>
       respect to any securities of the Company or to require the Company to
       include such securities with the Notes registered pursuant to any
       Registration Statement; and

           (iv)  after due inquiry, such counsel does not know of any legal or
       governmental proceedings pending or threatened to which the Company or
       any of its subsidiaries is or could be a party or to which any of their
       respective property is or could be subject, which might result, singly or
       in the aggregate, in a Material Adverse Effect.

        (h)  The Initial Purchasers shall have received on the Closing Date an
    opinion, dated the Closing Date, of Latham & Watkins, counsel for the
    Initial Purchasers, in form and substance reasonably satisfactory to the
    Initial Purchasers.

        (i)  The Initial Purchasers shall have received, at the Closing Date, a
    letter dated the Closing Date, as the case may be, in form and substance
    satisfactory to the Initial Purchasers from Arthur Andersen LLP, independent
    public accountants, containing the information and statements of the type
    ordinarily included in accountants' "comfort letters" to the Initial
    Purchasers with respect to the financial statements and certain financial
    information contained in the Offering Memorandum.

        (j)  You shall have received on the Closing Date an opinion
    (satisfactory to you and counsel for the Initial Purchasers), dated the
    Closing Date, of Friedman Kaplan & Seiler LLP, special counsel for the
    Company substantially to the effect that:

           (i)  the Series A Notes when executed and authenticated in accordance
       with the provisions of the Indenture and delivered to and paid for by the
       Initial Purchasers in accordance with the terms of this Agreement, will
       be entitled to the benefits of the Indenture and will be valid and
       binding obligations of the Company, enforceable in accordance with their
       terms except as (x) the enforceability thereof may be limited by
       bankruptcy, insolvency or similar laws affecting creditors' rights
       generally and (y) rights of acceleration and the availability of
       equitable remedies may be limited by equitable principles of general
       applicability;

           (ii)  the Indenture is a valid and binding agreement of the Company,
       enforceable against the Company in accordance with its terms except as
       (x) the enforceability thereof may be limited by bankruptcy, insolvency
       or similar laws affecting creditors' rights generally and (y) rights of
       acceleration and the availability of equitable remedies may be limited by
       equitable principles of general applicability; and

           (iii)  the Registration Rights Agreement is a valid and binding
       agreement of the Company, enforceable against the Company in accordance
       with its terms, except as (x) the enforceability thereof may be limited
       by bankruptcy, insolvency or similar laws affecting creditors' rights
       generally, (y) rights of acceleration and the availability of equitable
       remedies may be limited by equitable principles of general applicability
       and (z) indemnity provisions may be unenforceable as against public
       policy.

        (k)  The Series A Notes shall have been approved by the NASD for trading
    and duly listed in PORTAL.

        (l)  The Initial Purchasers shall have received a counterpart, conformed
    as executed, of the Indenture which shall have been entered into by the
    Company and the Trustee.

        (m)  The Company shall have executed the Registration Rights Agreement
    and the Initial Purchasers shall have received an original copy thereof,
    duly executed by the Company.

        (n)  The Company shall not have failed at or prior to the Closing Date
    to perform or comply with any of the agreements herein contained and
    required to be performed or complied with by the Company, as the case may
    be, at or prior to the Closing Date.

                                       19
<PAGE>
        (o)  The Company shall have obtained the consent of its lenders under
    the Credit Facility to the transactions contemplated by this Agreement,
    including the issuance of the Notes and the payment of interest thereon.

        (p)  As of the Closing Date, the Notes shall not have received a rating
    any lower than the rating received with respect to the Company's 14% Senior
    Discount Notes due 2009.

    10.  EFFECTIVENESS OF AGREEMENT AND TERMINATION.

    This Agreement shall become effective upon the execution and delivery of
this Agreement by the parties hereto.

    This Agreement may be terminated at any time on or prior to the Closing Date
by the Initial Purchasers by written notice to the Company if any of the
following has occurred: (i) any outbreak or escalation of hostilities or other
national or international calamity or crisis or change in economic conditions or
in the financial markets of the United States or elsewhere that, in DLJ's
judgment, is material and adverse and, in DLJ's judgment, makes it impracticable
to market the Series A Notes on the terms and in the manner contemplated in the
Offering Memorandum, (ii) the suspension or material limitation of trading in
securities or other instruments on the New York Stock Exchange, the American
Stock Exchange, the Chicago Board of Options Exchange, the Chicago Mercantile
Exchange, the Chicago Board of Trade or the Nasdaq National Market or limitation
on prices for securities or other instruments on any such exchange or the Nasdaq
National Market, (iii) the suspension of trading of any securities of the
Company on any exchange or in the over-the-counter market, (iv) the enactment,
publication, decree or other promulgation of any federal or state statute,
regulation, rule or order of any court or other governmental authority which in
the Initial Purchasers' reasonable judgment materially and adversely affects, or
will materially and adversely affect, the business, prospects, financial
condition or results of operations of the Company and its subsidiaries, taken as
a whole, (v) the declaration of a banking moratorium by either federal or New
York State authorities or (vi) the taking of any action by any federal, state or
local government or agency in respect of its monetary or fiscal affairs which in
DLJ's opinion has a material adverse effect on the financial markets in the
United States.

    If on the Closing Date any one or more of the Initial Purchasers shall fail
or refuse to purchase the Series A Notes which it or they have agreed to
purchase hereunder on such date and the aggregate principal amount of the
Series A Notes which such defaulting Initial Purchaser or Initial Purchasers, as
the case may be, agreed but failed or refused to purchase is not more than
one-tenth of the aggregate principal amount of the Series A Notes to be
purchased on such date by all Initial Purchasers, each non-defaulting Initial
Purchaser shall be obligated severally, in the proportion which the principal
amount of the Series A Notes set forth opposite its name in Schedule B bears to
the aggregate principal amount of the Series A Notes which all the
non-defaulting Initial Purchasers, as the case may be, have agreed to purchase,
or in such other proportion as you may specify, to purchase the Series A Notes
which such defaulting Initial Purchaser or Initial Purchasers, as the case may
be, agreed but failed or refused to purchase on such date; PROVIDED that in no
event shall the aggregate principal amount of the Series A Notes which any
Initial Purchaser has agreed to purchase pursuant to Section 2 hereof be
increased pursuant to this Section 10 by an amount in excess of one-ninth of
such principal amount of the Series A Notes without the written consent of such
Initial Purchaser. If on the Closing Date any Initial Purchaser or Initial
Purchasers shall fail or refuse to purchase the Series A Notes and the aggregate
principal amount of the Series A Notes with respect to which such default occurs
is more than one-tenth of the aggregate principal amount of the Series A Notes
to be purchased by all Initial Purchasers and arrangements satisfactory to the
Initial Purchasers and the Company for purchase of such Series A Notes are not
made within 48 hours after such default, this Agreement will terminate without
liability on the part of any non-defaulting Initial Purchaser or the Company. In
any such case which does not result in termination of this Agreement, either you
or the Company shall have the right to postpone the Closing Date, but in no
event for longer than seven days, in order that the required changes, if any, in
the Offering Memorandum or any other documents or

                                       20
<PAGE>
arrangements may be effected. Any action taken under this paragraph shall not
relieve any defaulting Initial Purchaser from liability in respect of any
default of any such Initial Purchaser under this Agreement.

    11.  INITIAL PURCHASERS' INFORMATION.

    The Company and the Initial Purchasers severally acknowledge and agree for
all purposes under this Agreement that the statements with respect to the
offering of the Notes set forth in the last paragraph of the outside front cover
page; the stabilization language in the first paragraph of page (ii); and the
first sentence of the third paragraph, the fourth sentence of the sixth
paragraph and the eighth paragraph under the caption "Plan of Distribution" in
such Offering Memorandum constitute the only information furnished to the
Company in writing by the Initial Purchasers expressly for use in the Offering
Memorandum.

    12.  MISCELLANEOUS.

    Notices given pursuant to any provision of this Agreement shall be addressed
as follows: (i) if to the Company, to 4500 Carillon Point, Kirkland, Washington
98033, Attention: Donald Manning, Esq. and (ii) if to the Initial Purchasers,
Donaldson, Lufkin & Jenrette Securities Corporation, as representative for the
Initial Purchasers, 277 Park Avenue, New York, New York 10172, Attention:
Syndicate Department, or in any case to such other address as the person to be
notified may have requested in writing.

    The respective indemnities, contribution agreements, representations,
warranties and other statements of the Company and the Initial Purchasers set
forth in or made pursuant to this Agreement shall remain operative and in full
force and effect, and will survive delivery of and payment for the Series A
Notes, regardless of (i) any investigation, or statement as to the results
thereof, made by or on behalf of the Initial Purchasers, the officers or
directors of the Initial Purchasers, any person controlling the Initial
Purchasers, the Company, the officers or directors of the Company, or any person
controlling the Company, (ii) acceptance of the Series A Notes and payment for
them hereunder and (iii) termination of this Agreement.

    (a) If for any reason the Series A Notes are not delivered by or on behalf
of the Company as provided herein (other than as a result of any termination of
this Agreement pursuant to Section 10 or the failure to satisfy the condition to
closing set forth in Section 9(o) above), the Company agrees to reimburse the
Initial Purchasers for all out-of-pocket expenses (including the fees and
disbursements of counsel) incurred by them. Notwithstanding any termination of
this Agreement, the Company shall be liable for all expenses which it has agreed
to pay pursuant to Section 5(i) hereof. The Company also agrees to reimburse the
Initial Purchasers and their officers, directors and each person, if any, who
controls such Initial Purchasers within the meaning of Section 15 of the Act or
Section 20 of the Exchange Act for any and all fees and expenses (including
without limitation the fees and expenses of counsel) incurred by them in
connection with enforcing their rights under this Agreement (including without
limitation its rights under Section 8). The Initial Purchasers agree to
reimburse the Company, and its directors and officers and each person, if any,
who controls (within the meaning of Section 15 of the Act or Section 20 of the
Exchange Act) the Company for any and all fees and expenses (including without
limitation the fees and expenses of counsel) incurred by them in connection with
enforcing their rights under this Agreement (including without limitation its
rights under Section 8).

    Except as otherwise provided, this Agreement has been and is made solely for
the benefit of and shall be binding upon the Company, the Initial Purchasers,
the Initial Purchasers' directors and officers, any controlling persons referred
to herein, the directors of the Company and their respective successors and
assigns, all as and to the extent provided in this Agreement, and no other
person shall acquire or have any right under or by virtue of this Agreement. The
term "successors and assigns" shall not include a purchaser of any of the
Series A Notes from the Initial Purchasers merely because of such purchase.

                                       21
<PAGE>
    THIS AGREEMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS
OF THE STATE OF NEW YORK.

    This Agreement may be signed in various counterparts which together shall
constitute one and the same instrument.

    Please confirm that the foregoing correctly sets forth the agreement among
the Company and the Initial Purchasers.

<TABLE>
<S>  <C>                                       <C>  <C>
                                               Very truly yours,

                                               NEXTEL PARTNERS, INC.

                                               By:  ---------------------------------------
                                                    Name:
                                                    Title:

DONALDSON, LUFKIN & JENRETTE
SECURITIES CORPORATION
DEUTSCHE BANK SECURITIES INC.
CIBC WORLD MARKETS CORP.

By:  DONALDSON, LUFKIN & JENRETTE
     SECURITIES CORPORATION

By:  ---------------------------------------
     Name:
     Title:
</TABLE>

                                       22
<PAGE>
                                   SCHEDULE A
                                  SUBSIDIARIES

Nextel Partners Operating Corp., Inc., a DE corp.

Nextel Partners of Upstate New York, Inc., a DE corp.

Nextel WIP Lease Corp. a DE corp.

Nextel WIP License Corp., a DE corp.

NPCR, Inc., a DE corp.

NPFC, Inc., a NV corp.

Nextel Partners Equipment Corp., a NV corp.
<PAGE>
                                   SCHEDULE B

<TABLE>
<CAPTION>
                                                              PRINCIPAL AMOUNT
INITIAL PURCHASERS                                                OF NOTES
------------------                                            ----------------
<S>                                                           <C>
Donaldson, Lufkin & Jenrette Securities Corporation.........    $145,000,000

Deutsche Bank Securities Inc................................    $ 30,000,000

CIBC World Markets Corp.....................................    $ 25,000,000
                                                                ------------

Total.......................................................    $200,000,000
                                                                ============
</TABLE>
<PAGE>
                                   EXHIBIT A
                     FORM OF REGISTRATION RIGHTS AGREEMENT

                                       i<PAGE>
                                                                   EXHIBIT 10.54

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

                                                                  EXECUTION COPY

                         REGISTRATION RIGHTS AGREEMENT

                           DATED AS OF JULY 27, 2000

                                  BY AND AMONG

                             NEXTEL PARTNERS, INC.,

                                      AND

              DONALDSON, LUFKIN & JENRETTE SECURITIES CORPORATION,
                       DEUTSCHE BANK SECURITIES INC. AND
                            CIBC WORLD MARKETS CORP.

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
<PAGE>
    This Registration Rights Agreement (this "AGREEMENT") is made and entered
into as of July 27, 2000, by and between Nextel Partners, Inc., a Delaware
corporation (the "COMPANY") and Donaldson, Lufkin & Jenrette Securities
Corporation, Deutsche Bank Securities Inc. and CIBC World Markets Corp. (the
"INITIAL PURCHASERS"), who have agreed to purchase the Company's 11% Senior
Notes due 2010 (the "SERIES A NOTES") pursuant to the Purchase Agreement (as
defined below).

    This Agreement is made pursuant to the Purchase Agreement, dated July 18,
2000, (the "PURCHASE AGREEMENT"), by and between the Company and the Initial
Purchasers. In order to induce the Initial Purchasers to purchase the Series A
Notes, the Company has agreed to provide the registration rights set forth in
this Agreement. The execution and delivery of this Agreement is a condition to
the obligations of the Initial Purchasers set forth in Section 3 of the Purchase
Agreement. Capitalized terms used herein and not otherwise defined shall have
the meaning assigned to them the Indenture, dated July 27, 2000, between the
Company and The Bank of New York, as Trustee, relating to the Series A Notes and
the Series B Notes (the "INDENTURE").

    The parties hereby agree as follows:

1  DEFINITIONS

    As used in this Agreement, the following capitalized terms shall have the
following meanings:

    ACT:  The Securities Act of 1933, as amended.

    AFFILIATE:  As defined in Rule 144 of the Act.

    BROKER-DEALER:  Any broker or dealer registered under the Exchange Act.

    CERTIFICATED SECURITIES:  Definitive Notes, as defined in the Indenture.

    CLOSING DATE:  The date hereof.

    COMMISSION:  The Securities and Exchange Commission.

    CONSUMMATE:  An Exchange Offer shall be deemed "Consummated" for purposes of
this Agreement upon the occurrence of (a) the filing and effectiveness under the
Act of the Exchange Offer Registration Statement relating to the Series B Notes
to be issued in the Exchange Offer, (b) the maintenance of such Exchange Offer
Registration Statement continuously effective and the keeping of the Exchange
Offer open for a period not less than the period required pursuant to
Section 3(b) hereof and (c) the delivery by the Company to the Registrar under
the Indenture of Series B Notes in the same aggregate principal amount as the
aggregate principal amount of Series A Notes tendered by Holders thereof
pursuant to the Exchange Offer.

    CONSUMMATION DEADLINE:  As defined in Section 3(b) hereof.

    EFFECTIVENESS DEADLINE:  As defined in Section 3(a) and 4(a) hereof.

    EXCHANGE ACT:  The Securities Exchange Act of 1934, as amended.

    EXCHANGE OFFER:  The exchange and issuance by the Company of a principal
amount of Series B Notes (which shall be registered pursuant to the Exchange
Offer Registration Statement) equal to the outstanding principal amount of
Series A Notes that are tendered by such Holders in connection with such
exchange and issuance.

    EXCHANGE OFFER REGISTRATION STATEMENT:  The Registration Statement relating
to the Exchange Offer, including the related Prospectus.

                                       1
<PAGE>
    EXEMPT RESALES:  The transactions in which the Initial Purchasers propose to
sell the Series A Notes to certain "qualified institutional buyers," as such
term is defined in Rule 144A under the Act and pursuant to Regulation S under
the Act.

    FILING DEADLINE:  As defined in Sections 3(a) and 4(a) hereof.

    HOLDERS:  As defined in Section 2 hereof.

    PROSPECTUS:  The prospectus included in a Registration Statement at the time
such Registration Statement is declared effective, as amended or supplemented by
any prospectus supplement and by all other amendments thereto, including
post-effective amendments, and all material incorporated by reference into such
Prospectus.

    RECOMMENCEMENT DATE:  As defined in Section 6(d) hereof.

    REGISTRATION DEFAULT:  As defined in Section 5 hereof.

    REGISTRATION STATEMENT:  Any registration statement of the Company relating
to (a) an offering of Series B Notes pursuant to an Exchange Offer or (b) the
registration for resale of Transfer Restricted Securities pursuant to the Shelf
Registration Statement, in each case, (i) that is filed pursuant to the
provisions of this Agreement and (ii) including the Prospectus included therein,
all amendments and supplements thereto (including post-effective amendments) and
all exhibits and material incorporated by reference therein.

    REGULATION S: Regulation S promulgated under the Act.

    RULE 144:  Rule 144 promulgated under the Act.

    SERIES B NOTES:  The Company's 11% Series B Senior Notes due 2010 to be
issued pursuant to the Indenture: (i) in the Exchange Offer or (ii) as
contemplated by Section 4 hereof.

    SHELF REGISTRATION STATEMENT:  As defined in Section 4 hereof.

    SUSPENSION NOTICE:  As defined in Section 6(d) hereof.

    TIA:  The Trust Indenture Act of 1939 (15 U.S.C. Section 77aaa-77bbbb) as in
effect on the date of the Indenture.

    TRANSFER RESTRICTED SECURITIES:  Each (A) Series A Note, until the earliest
to occur of (i) the date on which such Series A Note is exchanged in the
Exchange Offer for a Series B Note which is entitled to be resold to the public
by the Holder thereof without complying with the prospectus delivery
requirements of the Act, (ii) the date on which such Series A Note has been
disposed of in accordance with a Shelf Registration Statement (and the
purchasers thereof have been issued Series B Notes), or (iii) the date on which
such Series A Note is distributed to the public pursuant to Rule 144 under the
Act and each (B) Series B Note held by a Broker Dealer until the date on which
such Series B Note is disposed of by a Broker-Dealer pursuant to the "Plan of
Distribution" contemplated by the Exchange Offer Registration Statement
(including the delivery of the Prospectus contained therein).

2  HOLDERS

    A Person is deemed to be a holder of Transfer Restricted Securities (each, a
"HOLDER") whenever such Person owns Transfer Restricted Securities.

                                       2
<PAGE>
3  REGISTERED EXCHANGE OFFER

    (a)  Unless the Exchange Offer shall not be permitted by applicable federal
law (after the procedures set forth in Section 6(a)(i) below have been complied
with), the Company shall (i) cause the Exchange Offer Registration Statement to
be filed with the Commission as soon as practicable after the Closing Date, but
in no event later than 120 days after the Closing Date (such 120th day being the
"FILING DEADLINE"), (ii) use all commercially reasonable efforts to cause such
Exchange Offer Registration Statement to become effective at the earliest
possible time, but in no event later than 180 days after the Closing Date (such
180th day being the "EFFECTIVENESS DEADLINE"), (iii) in connection with the
foregoing, (A) file all pre-effective amendments to such Exchange Offer
Registration Statement as may be necessary in order to cause it to become
effective, (B) file, if applicable, a post-effective amendment to such Exchange
Offer Registration Statement pursuant to Rule 430A under the Act and (C) cause
all necessary filings, if any, in connection with the registration and
qualification of the Series B Notes to be made under the Blue Sky laws of such
jurisdictions as are necessary to permit Consummation of the Exchange Offer, and
(iv) upon the effectiveness of such Exchange Offer Registration Statement,
commence and Consummate the Exchange Offer. The Exchange Offer shall be on the
appropriate form permitting (i) registration of the Series B Notes to be offered
in exchange for the Series A Notes that are Transfer Restricted Securities and
(ii) resales of Series B Notes by Broker-Dealers that tendered into the Exchange
Offer Series A Notes that such Broker-Dealer acquired for its own account as a
result of market making activities or other trading activities (other than
Series A Notes acquired directly from the Company or any of its Affiliates) as
contemplated by Section 3(c) below.

    (b)  The Company shall use all commercially reasonable efforts to cause the
Exchange Offer Registration Statement to be effective continuously, and shall
keep the Exchange Offer open for a period of not less than the minimum period
required under applicable federal and state securities laws to Consummate the
Exchange Offer; PROVIDED, HOWEVER, that in no event shall such period be less
than 20 Business Days. The Company shall cause the Exchange Offer to comply with
all applicable federal and state securities laws. No securities other than the
Series B Notes shall be included in the Exchange Offer Registration Statement.
The Company shall use all commercially reasonable efforts to cause the Exchange
Offer to be Consummated on the earliest practicable date after the Exchange
Offer Registration Statement has become effective, but in no event later than 30
business days thereafter (such 30th day being the "CONSUMMATION DEADLINE").

    (c)  The Company shall include a "Plan of Distribution" section in the
Prospectus contained in the Exchange Offer Registration Statement and indicate
therein that any Broker-Dealer who holds Transfer Restricted Securities that
were acquired for the account of such Broker-Dealer as a result of market-
making activities or other trading activities (other than Series A Notes
acquired directly from the Company or any Affiliate of the Company), may
exchange such Transfer Restricted Securities pursuant to the Exchange Offer.
Such "Plan of Distribution" section shall also contain all other information
with respect to such sales by such Broker-Dealers that the Commission may
require in order to permit such sales pursuant thereto, but such "Plan of
Distribution" shall not name any such Broker-Dealer or disclose the amount of
Transfer Restricted Securities held by any such Broker-Dealer, except to the
extent required by the Commission as a result of a change in policy, rules or
regulations after the date of this Agreement.

    Because such Broker-Dealer may be deemed to be an "underwriter" within the
meaning of the Act and must, therefore, deliver a prospectus meeting the
requirements of the Act in connection with its initial sale of any Series B
Notes received by such Broker-Dealer in the Exchange Offer, the Company shall
permit the use of the Prospectus contained in the Exchange Offer Registration
Statement by such Broker-Dealer to satisfy such prospectus delivery requirement.
To the extent necessary to ensure that the prospectus contained in the Exchange
Offer Registration Statement is available for sales of Series B Notes by
Broker-Dealers, the Company agrees to use all commercially reasonable efforts to
keep the Exchange Offer Registration Statement continuously effective,
supplemented, amended and current as required by and subject to the provisions
of Section 6(a) and (c) hereof and in conformity with the requirements of this

                                       3
<PAGE>
Agreement, the Act and the policies, rules and regulations of the Commission as
announced from time to time, for a period of one year from the Consummation
Deadline or such shorter period as will terminate when all Transfer Restricted
Securities covered by such Registration Statement have been sold pursuant
thereto. The Company shall provide sufficient copies of the latest version of
such Prospectus to such Broker-Dealers, promptly upon request, and in no event
later than one day after such request, at any time during such period.

4  SHELF REGISTRATION

    (a)  SHELF REGISTRATION. If (i) the Exchange Offer is not permitted by
applicable law (after the Company has complied with the procedures set forth in
Section 6(a)(i) below) or (ii) if any Holder of Transfer Restricted Securities
shall notify the Company within 20 Business Days following the Consummation
Deadline that (A) such Holder was prohibited by law or Commission policy from
participating in the Exchange Offer or (B) such Holder may not resell the
Series B Notes acquired by it in the Exchange Offer to the public without
delivering a prospectus and the Prospectus contained in the Exchange Offer
Registration Statement is not appropriate or available for such resales by such
Holder or (C) such Holder is a Broker-Dealer and holds Series A Notes acquired
directly from the Company or any of its Affiliates, then the Company shall:

        (x)  cause to be filed, on or prior to 60 days after the earlier of
    (i) the date on which the Company determines that the Exchange Offer
    Registration Statement cannot be filed as a result of clause (a)(i) above
    and (ii) the date on which the Company receives the notice specified in
    clause (a)(ii) above, (such earlier date, the "FILING DEADLINE"), a shelf
    registration statement pursuant to Rule 415 under the Act (which may be an
    amendment to the Exchange Offer Registration Statement (the "SHELF
    REGISTRATION STATEMENT")), relating to all Transfer Restricted Securities,
    and

        (y)  shall use all commercially reasonable efforts to cause such Shelf
    Registration Statement to become effective on or prior to 90 days after the
    Filing Deadline for the Shelf Registration Statement (such 90th day the
    "EFFECTIVENESS DEADLINE").

    If, after the Company has filed an Exchange Offer Registration Statement
that satisfies the requirements of Section 3(a) above, the Company is required
to file and make effective a Shelf Registration Statement solely because the
Exchange Offer is not permitted under applicable federal law (i.e.,
clause (a)(i) above), then the filing of the Exchange Offer Registration
Statement shall be deemed to satisfy the requirements of clause (x) above;
PROVIDED that, in such event, the Company shall remain obligated to meet the
Effectiveness Deadline set forth in clause (y).

    To the extent necessary to ensure that the Shelf Registration Statement is
available for sales of Transfer Restricted Securities by the Holders thereof
entitled to the benefit of this Section 4(a) and the other securities required
to be registered therein pursuant to Section 6(b)(ii) hereof, the Company shall
use all commercially reasonable efforts to keep any Shelf Registration Statement
required by this Section 4(a) continuously effective, supplemented, amended and
current as required by and subject to the provisions of Sections 6(b) and
(c) hereof and in conformity with the requirements of this Agreement, the Act
and the policies, rules and regulations of the Commission as announced from time
to time, for as long as the Initial Purchasers are deemed to be affiliates of
the Company but in no event less than the shorter of (i) two years (as extended
pursuant to Section 6(c)(i)) following the Closing or (ii) the date on which all
Transfer Restricted Securities covered by such Shelf Registration Statement have
been sold pursuant thereto.

    (b)  PROVISION BY HOLDERS OF CERTAIN INFORMATION IN CONNECTION WITH THE
SHELF REGISTRATION STATEMENT. No Holder of Transfer Restricted Securities may
include any of its Transfer Restricted Securities in any Shelf Registration
Statement pursuant to this Agreement unless and until such Holder furnishes to
the Company in writing, within 20 days after receipt of a request therefor, the
information specified in Item 507 or 508 of Regulation S-K, as applicable, of
the Act for use in connection with any Shelf Registration Statement or

                                       4
<PAGE>
Prospectus or preliminary Prospectus included therein. No Holder of Transfer
Restricted Securities shall be entitled to liquidated damages pursuant to
Section 5 hereof unless and until such Holder shall have provided all such
information. Each selling Holder agrees to promptly furnish additional
information required to be disclosed in order to make the information previously
furnished to the Company by such Holder not materially misleading.

5  LIQUIDATED DAMAGES

    If (i) any Registration Statement required by this Agreement is not filed
with the Commission on or prior to the applicable Filing Deadline, (ii) any such
Registration Statement has not been declared effective by the Commission on or
prior to the applicable Effectiveness Deadline, (iii) the Exchange Offer has not
been Consummated on or prior to the Consummation Deadline or (iv) any
Registration Statement required by this Agreement is filed and declared
effective but shall thereafter cease to be effective or fail to be usable for
its intended purpose without being succeeded within 2 days by a post-effective
amendment to such Registration Statement that cures such failure and that is
itself declared effective within 5 days of filing such post-effective amendment
to such Registration Statement (each such event referred to in clauses
(i) through (iv), a "REGISTRATION DEFAULT"), then the Company agrees to pay to
each Holder of Transfer Restricted Securities affected thereby liquidated
damages in an amount equal to $.05 per week per $1,000 in principal amount of
Transfer Restricted Securities held by such Holder for each week or portion
thereof that the Registration Default continues for the first 90-day period
immediately following the occurrence of such Registration Default. The amount of
the liquidated damages shall increase by an additional $.05 per week per $1,000
in principal amount of Transfer Restricted Securities with respect to each
subsequent 90-day period until all Registration Defaults have been cured, up to
a maximum amount of liquidated damages of $.50 per week per $1,000 in principal
amount of Transfer Restricted Securities; PROVIDED that the Company shall in no
event be required to pay liquidated damages for more than one Registration
Default at any given time. Notwithstanding anything to the contrary set forth
herein, (1) upon filing of the Exchange Offer Registration Statement (and/or, if
applicable, the Shelf Registration Statement), in the case of (i) above,
(2) upon the effectiveness of the Exchange Offer Registration Statement (and/or,
if applicable, the Shelf Registration Statement), in the case of (ii) above,
(3) upon Consummation of the Exchange Offer, in the case of (iii) above, or
(4) upon the filing of a post-effective amendment to the Registration Statement
or an additional Registration Statement that causes the Exchange Offer
Registration Statement (and/or, if applicable, the Shelf Registration Statement)
to again be declared effective or made usable in the case of (iv) above, the
liquidated damages payable with respect to the Transfer Restricted Securities as
a result of such clause (i), (ii), (iii) or (iv), as applicable, shall cease.

    All accrued liquidated damages shall be paid to the Holders entitled
thereto, in the manner provided for the payment of interest in the Indenture, on
each Interest Payment Date, as more fully set forth in the Indenture and the
Notes. Notwithstanding the fact that any securities for which liquidated damages
are due cease to be Transfer Restricted Securities, all obligations of the
Company to pay liquidated damages with respect to securities shall survive until
such time as such obligations with respect to such securities shall have been
satisfied in full.

6  REGISTRATION PROCEDURES

    (a)  EXCHANGE OFFER REGISTRATION STATEMENT. In connection with the Exchange
Offer, the Company shall (x) comply with all applicable provisions of
Section 6(c) below, (y) use all commercially reasonable efforts to effect such
exchange and to permit the resale of Series B Notes by Broker-Dealers that
tendered in the Exchange Offer Series A Notes that such Broker-Dealer acquired
for its own account as a result of its market making activities or other trading
activities (other than Series A Notes acquired directly from the Company or any
of its Affiliates) being sold in accordance with the intended method or methods
of distribution thereof, and (z) comply with all of the following provisions:

                                       5
<PAGE>
        (i)  If, following the date hereof there has been announced a change in
    Commission policy with respect to exchange offers such as the Exchange
    Offer, that in the reasonable opinion of counsel to the Company raises a
    substantial question as to whether the Exchange Offer is permitted by
    applicable federal law, the Company hereby agrees to seek a no-action letter
    or other favorable decision from the Commission allowing the Company to
    Consummate an Exchange Offer for such Transfer Restricted Securities. The
    Company hereby agrees to pursue the issuance of such a decision to the
    Commission staff level. In connection with the foregoing, the Company hereby
    agrees to take all such other actions as may be requested by the Commission
    or otherwise required in connection with the issuance of such decision,
    including without limitation (A) participating in telephonic conferences
    with the Commission, (B) delivering to the Commission staff an analysis
    prepared by counsel to the Company setting forth the legal bases, if any,
    upon which such counsel has concluded that such an Exchange Offer should be
    permitted and (C) diligently pursuing a resolution (which need not be
    favorable) by the Commission staff.

        (ii)  As a condition to its participation in the Exchange Offer, each
    Holder of Transfer Restricted Securities (including, without limitation, any
    Holder who is a Broker Dealer) shall furnish, upon the request of the
    Company, prior to the Consummation of the Exchange Offer, a written
    representation to the Company (which may be contained in the letter of
    transmittal contemplated by the Exchange Offer Registration Statement) to
    the effect that (A) it is not an Affiliate of the Company, (B) it is not
    engaged in, and does not intend to engage in, and has no arrangement or
    understanding with any person to participate in, a distribution of the
    Series B Notes to be issued in the Exchange Offer and (C) it is acquiring
    the Series B Notes in its ordinary course of business. As a condition to its
    participation in the Exchange Offer each Holder using the Exchange Offer to
    participate in a distribution of the Series B Notes shall acknowledge and
    agree that, if the resales are of Series B Notes obtained by such Holder in
    exchange for Series A Notes acquired directly from the Company or an
    Affiliate thereof, it (1) could not, under Commission policy as in effect on
    the date of this Agreement, rely on the position of the Commission
    enunciated in MORGAN STANLEY AND CO., INC. (available June 5, 1991) and
    EXXON CAPITAL HOLDINGS CORPORATION (available May 13, 1988), as interpreted
    in the Commission's letter to SHEARMAN & STERLING dated July 2, 1993, and
    similar no-action letters (including, if applicable, any no-action letter
    obtained pursuant to clause (i) above), and (2) must comply with the
    registration and prospectus delivery requirements of the Act in connection
    with a secondary resale transaction and that such a secondary resale
    transaction must be covered by an effective registration statement
    containing the selling security holder information required by Item 507 or
    508, as applicable, of Regulation S-K.

        (iii)  Prior to effectiveness of the Exchange Offer Registration
    Statement, the Company shall provide a supplemental letter to the Commission
    (A) stating that the Company is registering the Exchange Offer in reliance
    on the position of the Commission enunciated in EXXON CAPITAL HOLDINGS
    CORPORATION (available May 13, 1988), MORGAN STANLEY AND CO., INC.
    (available June 5, 1991) as interpreted in the Commission's letter to
    SHEARMAN & STERLING dated July 2, 1993, and, if applicable, any no-action
    letter obtained pursuant to clause (i) above, (B) including a representation
    that the Company has not entered into any arrangement or understanding with
    any Person to distribute the Series B Notes to be received in the Exchange
    Offer and that, to the best of the Company's information and belief, each
    Holder participating in the Exchange Offer is acquiring the Series B Notes
    in its ordinary course of business and has no arrangement or understanding
    with any Person to participate in the distribution of the Series B Notes
    received in the Exchange Offer and (C) any other undertaking or
    representation required by the Commission as set forth in any no-action
    letter obtained pursuant to clause (i) above, if applicable.

                                       6
<PAGE>
    (b)  SHELF REGISTRATION STATEMENT. In connection with the Shelf Registration
Statement, the Company shall:

        (i)  comply with all the provisions of Section 6(c) below and use all
    commercially reasonable efforts to effect such registration to permit the
    sale of the Transfer Restricted Securities being sold in accordance with the
    intended method or methods of distribution thereof (as indicated in the
    information furnished to the Company pursuant to Section 4(b) hereof), and
    pursuant thereto the Company will prepare and file with the Commission a
    Registration Statement relating to the registration on any appropriate form
    under the Act, which form shall be available for the sale of the Transfer
    Restricted Securities in accordance with the intended method or methods of
    distribution thereof within the time periods and otherwise in accordance
    with the provisions hereof, and

        (ii)  issue, upon the request of any Holder or purchaser of Series A
    Notes covered by any Shelf Registration Statement contemplated by this
    Agreement, Series B Notes having an aggregate principal amount equal to the
    aggregate principal amount of Series A Notes sold pursuant to the Shelf
    Registration Statement and surrendered to the Company for cancellation; the
    Company shall register Series B Notes on the Shelf Registration Statement
    for this purpose and issue the Series B Notes to the purchaser(s) of
    securities subject to the Shelf Registration Statement in the names as such
    purchaser(s) shall designate.

    (c)  GENERAL PROVISIONS. In connection with any Registration Statement and
any related Prospectus required by this Agreement, the Company shall:

        (i)  use all commercially reasonable efforts to keep such Registration
    Statement continuously effective and provide all requisite financial
    statements for the period specified in Section 3 or 4 of this Agreement, as
    applicable. Upon the occurrence of any event that would cause any such
    Registration Statement or the Prospectus contained therein (A) to contain an
    untrue statement of material fact or omit to state any material fact
    necessary to make the statements therein not misleading or (B) not to be
    effective and usable for resale of Transfer Restricted Securities during the
    period required by this Agreement, the Company shall file promptly an
    appropriate amendment to such Registration Statement curing such defect,
    and, if Commission review is required, use all commercially reasonable
    efforts to cause such amendment to be declared effective as soon as
    practicable. Notwithstanding anything to the contrary set forth in this
    Agreement, the Company's obligations to use all commercially reasonable
    efforts to keep the Shelf Registration Statement continuously effective,
    supplemented and amended shall be suspended in the event continued
    effectiveness of the Shelf Registration Statement or its use by Holders
    would, in the opinion of counsel to the Company, require the Company to
    disclose a material financing, acquisition or other corporate transaction,
    and the Board of Directors of the Company shall have determined in good
    faith that such disclosure is not in the best interests of the Company, but
    in no event will any such suspension, individually or in the aggregate,
    exceed 30 days within any twelve month period during which the Shelf
    Registration Statement is otherwise required to be effective;

        (ii)  prepare and file with the Commission such amendments and
    post-effective amendments to the applicable Registration Statement as may be
    necessary to keep such Registration Statement effective for the applicable
    period set forth in Section 3 or 4 hereof, as the case may be; cause the
    Prospectus to be supplemented by any required Prospectus supplement, and as
    so supplemented to be filed pursuant to Rule 424 under the Act, and to
    comply fully with Rules 424, 430A and 462, as applicable, under the Act in a
    timely manner; and comply with the provisions of the Act with respect to the
    disposition of all securities covered by such Registration Statement during
    the applicable period in accordance with the intended method or methods of
    distribution by the sellers thereof set forth in such Registration Statement
    or supplement to the Prospectus;

        (iii)  advise each Holder and each Initial Purchaser who is required to
    deliver a prospectus in connection with sales or market making activities
    promptly and, if requested by such Person, confirm

                                       7
<PAGE>
    such advice in writing, (A) when the Prospectus or any Prospectus supplement
    or post-effective amendment has been filed, and, with respect to any
    applicable Registration Statement or any post-effective amendment thereto,
    when the same has become effective, (B) of any request by the Commission for
    amendments to the Registration Statement or amendments or supplements to the
    Prospectus or for additional information relating thereto, (C) of the
    issuance by the Commission of any stop order suspending the effectiveness of
    the Registration Statement under the Act or of the suspension by any state
    securities commission of the qualification of the Transfer Restricted
    Securities for offering or sale in any jurisdiction, or the initiation of
    any proceeding for any of the preceding purposes, (D) of the existence of
    any fact or the happening of any event that makes any statement of a
    material fact made in the Registration Statement, the Prospectus, any
    amendment or supplement thereto or any document incorporated by reference
    therein untrue, or that requires the making of any additions to or changes
    in the Registration Statement in order to make the statements therein not
    misleading, or that requires the making of any additions to or changes in
    the Prospectus in order to make the statements therein, in the light of the
    circumstances under which they were made, not misleading. If at any time the
    Commission shall issue any stop order suspending the effectiveness of the
    Registration Statement, or any state securities commission or other
    regulatory authority shall issue an order suspending the qualification or
    exemption from qualification of the Transfer Restricted Securities under
    state securities or Blue Sky laws, the Company shall use all commercially
    reasonable efforts to obtain the withdrawal or lifting of such order at the
    earliest possible time;

        (iv)  subject to Section 6(c)(i), if any fact or event contemplated by
    Section 6(c)(iii)(D) above shall exist or have occurred, prepare a
    supplement or post-effective amendment to the Registration Statement or
    related Prospectus or any document incorporated therein by reference or file
    any other required document so that, as thereafter delivered to the
    purchasers of Transfer Restricted Securities, the Prospectus will not
    contain an untrue statement of a material fact or omit to state any material
    fact necessary to make the statements therein, in the light of the
    circumstances under which they were made, not misleading;

        (v)  furnish to each Holder in connection with such exchange or sale, if
    any, before filing with the Commission, copies of any Registration Statement
    or any Prospectus included therein or any amendments or supplements to any
    such Registration Statement or Prospectus (including all documents
    incorporated by reference after the initial filing of such Registration
    Statement), which documents will be subject to the review and comment of
    such Persons in connection with such sale, if any, for a period of at least
    five Business Days, and the Company will not file any such Registration
    Statement or Prospectus or any amendment or supplement to any such
    Registration Statement or Prospectus (including all such documents
    incorporated by reference) to which such Persons shall reasonably object
    within five Business Days after the receipt thereof. Such Person shall be
    deemed to have reasonably objected to such filing if such Registration
    Statement, amendment, Prospectus or supplement, as applicable, as proposed
    to be filed, contains an untrue statement of a material fact or omit to
    state any material fact necessary to make the statements therein not
    misleading or fails to comply with the applicable requirements of the Act;

        (vi)  promptly prior to the filing of any document that is to be
    incorporated by reference into a Registration Statement or Prospectus,
    provide copies of such document to each Holder in connection with such
    exchange or sale, if any, make the Company's representatives as shall be
    reasonably requested by the Holders or their counsel available for
    discussion of such document and other customary due diligence matters, and
    include such information in such document prior to the filing thereof as
    such Persons may reasonably request;

PROVIDED, HOWEVER, that such Persons shall first agree in writing with the
Company that any information that is reasonably and in good faith designated by
the Company in writing as confidential at the time of delivery of such
information shall be kept confidential by such Persons, unless (i) disclosure of
such information is required by court or administrative order or is necessary to
respond to inquires of regulatory authorities,

                                       8
<PAGE>
(ii) disclosure of such information is required by law (including any disclosure
requirements pursuant to federal securities laws in connection with the filing
of such Registration Statement or the use of any Prospectus), (iii) such
information becomes generally available to the public other than as a result of
a disclosure or failure to safeguard such information by such Person or
(iv) such information becomes available to such Person from a source other than
the Company and its subsidiaries and such source is not known, after due
inquiry, by such Person to be bound by a confidentiality agreement; PROVIDED
FURTHER, that the foregoing investigation shall be coordinated on behalf of such
Persons by one representative designated by and on behalf of such Persons and
any such confidential information shall be available from such representative to
such Persons so long as any Person agrees to be bound by such confidentiality
agreement;

        (vii)  make available, at reasonable times, for inspection by each
    Holder and any attorney or accountant retained by such Persons, all
    financial and other records, pertinent corporate documents of the Company as
    may be reasonably requested and cause the Company's officers, directors and
    employees to supply all information reasonably requested by any such
    Persons, attorney or accountant in connection with such Registration
    Statement or any post-effective amendment thereto subsequent to the filing
    thereof and prior to its effectiveness;

        (viii)  if requested by any Holders in connection with such exchange or
    sale, promptly include in any Registration Statement or Prospectus, pursuant
    to a supplement or post-effective amendment if necessary, such information
    as such Persons may reasonably request to have included therein, including,
    without limitation, information relating to the "Plan of Distribution" of
    the Transfer Restricted Securities and the use of the Registration Statement
    or Prospectus for market making activities; and make all required filings of
    such Prospectus supplement or post-effective amendment as soon as
    practicable after the Company is notified of the matters to be included in
    such Prospectus supplement or post-effective amendment;

        (ix)  furnish to each Holder in connection with such exchange or sale,
    without charge, at least one copy of the Registration Statement, as first
    filed with the Commission, and of each amendment thereto, and, if requested
    all documents incorporated by reference therein and all exhibits (and, if
    requested exhibits incorporated therein by reference);

        (x)  deliver to each Holder without charge, as many copies of the
    Prospectus (including each preliminary prospectus) and any amendment or
    supplement thereto as such Persons reasonably may request; the Company
    hereby consents to the use (in accordance with law) of the Prospectus and
    any amendment or supplement thereto by each selling Person in connection
    with the offering and the sale of the Transfer Restricted Securities covered
    by the Prospectus or any amendment or supplement thereto;

        (xi)  upon the request of any Holder, enter into such agreements and
    make such representations and warranties and take all such other actions in
    connection therewith in order to expedite or facilitate the disposition of
    the Transfer Restricted Securities pursuant to any applicable Registration
    Statement contemplated by this Agreement as may be reasonably requested by
    any Holder in connection with any sale or resale pursuant to any applicable
    Registration Statement. In such connection, the Company shall:

           (A)  upon request of any Person, furnish (or in the case of
       paragraphs (2) and (3), all commercially reasonable efforts to cause to
       be furnished) to each Person, upon Consummation of the Exchange Offer or
       upon the effectiveness of the Shelf Registration Statement, as the case
       may be:

               (1)  a certificate, dated such date, signed on behalf of the
           Company by (x) the President or any Vice President and (y) a
           principal financial or accounting officer of the Company, confirming,
           as of the date thereof, the matters set forth in Sections 9(a), 9(b)
           and

                                       9
<PAGE>
           9(c) of the Purchase Agreement and such other similar matters as such
           Person may reasonably request;

               (2)  an opinion, dated the date of Consummation of the Exchange
           Offer or the date of effectiveness of the Shelf Registration
           Statement, as the case may be, of counsel for the Company covering
           matters similar to those set forth in paragraph (e) of Section 9 of
           the Purchase Agreement and such other matter as such Person may
           reasonably request. Without limiting the foregoing, such counsel may
           state further that such counsel assumes no responsibility for, and
           has not independently verified, the accuracy, completeness or
           fairness of the financial statements, notes and schedules and other
           financial data included in any Registration Statement contemplated by
           this Agreement or the related Prospectus; and

               (3)  a customary comfort letter, dated the date of Consummation
           of the Exchange Offer, or as of the date of effectiveness of the
           Shelf Registration Statement, as the case may be, from the Company's
           independent accountants, in the customary form and covering matters
           of the type customarily covered in comfort letters to underwriters in
           connection with underwritten offerings, and affirming the matters set
           forth in the comfort letters delivered pursuant to Section 9(j) of
           the Purchase Agreement, and

           (B)  deliver such other documents and certificates as may be
       reasonably requested by such Persons to evidence compliance with the
       matters covered in clause (A) above and with any customary conditions
       contained in any agreement entered into by the Company pursuant to this
       clause (xi);

        (xii)  prior to any public offering of Transfer Restricted Securities,
    cooperate with the selling Holders and their counsel in connection with the
    registration and qualification of the Transfer Restricted Securities under
    the securities or Blue Sky laws of such jurisdictions as the selling Holders
    may request and do any and all other acts or things necessary or advisable
    to enable the disposition in such jurisdictions of the Transfer Restricted
    Securities covered by the applicable Registration Statement; PROVIDED,
    HOWEVER, that the Company shall not be required to register or qualify as a
    foreign corporation where it is not now so qualified or to take any action
    that would subject it to the service of process in suits or to taxation,
    other than as to matters and transactions relating to the Registration
    Statement, in any jurisdiction where it is not now so subject;

        (xiii)  in connection with any sale of Transfer Restricted Securities
    that will result in such securities no longer being Transfer Restricted
    Securities, cooperate with the Holders to facilitate the timely preparation
    and delivery of certificates representing Transfer Restricted Securities to
    be sold and not bearing any restrictive legends; and to register such
    Transfer Restricted Securities in such denominations and such names as the
    selling Holders may request at least two Business Days prior to such sale of
    Transfer Restricted Securities;

        (xiv)  use all commercially reasonable efforts to cause the disposition
    of the Transfer Restricted Securities covered by the Registration Statement
    to be registered with or approved by such other governmental agencies or
    authorities as may be necessary to enable the seller or sellers thereof to
    consummate the disposition of such Transfer Restricted Securities, subject
    to the proviso contained in clause (xii) above;

        (xv)  provide a CUSIP number for all Transfer Restricted Securities not
    later than the effective date of a Registration Statement covering such
    Transfer Restricted Securities and provide the Trustee under the Indenture
    with printed certificates for the Transfer Restricted Securities which are
    in a form eligible for deposit with the Depository Trust Company;

        (xvi)  otherwise use all commercially reasonable efforts to comply with
    all applicable rules and regulations of the Commission, and make generally
    available to its security holders with regard to any applicable Registration
    Statement, as soon as practicable, a consolidated earnings statement meeting

                                       10
<PAGE>
    the requirements of Rule 158 (which need not be audited) covering a
    twelve-month period beginning after the effective date of the Registration
    Statement (as such term is defined in paragraph (c) of Rule 158 under the
    Act);

        (xvii)  cause the Indenture to be qualified under the TIA not later than
    the effective date of the first Registration Statement required by this
    Agreement and, in connection therewith, cooperate with the Trustee and the
    Holders to effect such changes to the Indenture as may be required for such
    Indenture to be so qualified in accordance with the terms of the TIA; and
    execute and use all commercially reasonable efforts to cause the Trustee to
    execute, all documents that may be required to effect such changes and all
    other forms and documents required to be filed with the Commission to enable
    such Indenture to be so qualified in a timely manner; and

        (xviii)  provide promptly to each Holder, upon request, each document
    filed with the Commission pursuant to the requirements of Section 13 or
    Section 15(d) of the Exchange Act.

    (d)  RESTRICTIONS ON HOLDERS. Each Holder agrees by acquisition of a
Transfer Restricted Security that, upon receipt of the notice referred to in
Section 6(c)(iii)(C) or any notice from the Company of the existence of any fact
of the kind described in Section 6(c)(iii)(D) hereof (in each case, a
"SUSPENSION NOTICE"), such Person will forthwith discontinue disposition of
Transfer Restricted Securities pursuant to the applicable Registration Statement
until (i) such Person has received copies of the supplemented or amended
Prospectus contemplated by Section 6(c)(iv) hereof, or (ii) such Person is
advised in writing by the Company that the use of the Prospectus may be resumed,
and has received copies of any additional or supplemental filings that are
incorporated by reference in the Prospectus (in each case, the "RECOMMENCEMENT
DATE"). Each Person receiving a Suspension Notice hereby agrees that it will
either (i) destroy any Prospectuses, other than permanent file copies, then in
such Person's possession which have been replaced by the Company with more
recently dated Prospectuses or (ii) deliver to the Company (at the Company's
expense) all copies, other than permanent file copies, then in such Person's
possession of the Prospectus covering such Transfer Restricted Securities that
was current at the time of receipt of the Suspension Notice. The time period
regarding the effectiveness of such Registration Statement set forth in
Section 3 or 4 hereof, as applicable, shall be extended by a number of days
equal to the number of days in the period from and including the date of
delivery of the Suspension Notice to the date of delivery of the Recommencement
Date.

7  REGISTRATION EXPENSES

    (a)  All expenses incident to the Company's performance of or compliance
with Sections 3 and 4 of this Agreement will be borne by the Company, regardless
of whether a Registration Statement becomes effective, including without
limitation: (i) all registration and filing fees and expenses; (ii) all fees and
expenses of compliance with federal securities and state Blue Sky or securities
laws; (iii) all expenses of printing (including printing certificates for the
Series B Notes to be issued in the Exchange Offer and printing of Prospectuses
whether for exchanges, sales, market making or otherwise), messenger and
delivery services and telephone; (iv) all fees and disbursements of counsel for
the Company and not more than one counsel for the Holders of Transfer Restricted
Securities; (v) all application and filing fees in connection with listing the
Series B Notes on a national securities exchange or automated quotation system
pursuant to the requirements hereof; and (vi) all fees and disbursements of
independent certified public accountants of the Company (including the expenses
of any special audit and comfort letters required by or incident to such
performance).

    The Company will, in any event, bear its internal expenses (including,
without limitation, all salaries and expenses of its officers and employees
performing legal or accounting duties), the expenses of any annual audit and the
fees and expenses of any Person, including special experts, retained by the
Company.

    Each Holder shall pay all underwriters discounts and commissions.

                                       11
<PAGE>
    (b)  In connection with any Registration Statement required by this
Agreement (including, without limitation, the Exchange Offer Registration
Statement and the Shelf Registration Statement), the Company will reimburse the
Initial Purchasers and the Holders of Transfer Restricted Securities who are
tendering Series A Notes into in the Exchange Offer and/or selling or reselling
Series A Notes or Series B Notes pursuant to the "Plan of Distribution"
contained in the Exchange Offer Registration Statement or the Shelf Registration
Statement, as applicable, for the reasonable fees and disbursements of not more
than one counsel, who shall be Latham & Watkins, unless another firm shall be
chosen by the Holders of a majority in principal amount of the Transfer
Restricted Securities for whose benefit such Registration Statement is being
prepared.

8  INDEMNIFICATION

    (a)  The Company agrees to indemnify and hold harmless each Holder, its
directors, officers and each Person, if any, who controls such Holder (within
the meaning of Section 15 of the Act or Section 20 of the Exchange Act), from
and against any and all losses, claims, damages, liabilities, judgments,
(including without limitation, any legal or other expenses incurred in
connection with investigating or defending any matter, including any action that
could give rise to any such losses, claims, damages, liabilities or judgments)
caused by any untrue statement or alleged untrue statement of a material fact
contained in any Registration Statement, preliminary prospectus or Prospectus
(or any amendment or supplement thereto) provided by the Company to any Holder
or any prospective purchaser of Series B Notes or registered Series A Notes, or
caused by any untrue statement or alleged untrue statement of a material fact or
omission or alleged omission to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading,
except insofar as such losses, claims, damages, liabilities or judgments are
caused by an untrue statement or omission or alleged untrue statement or
omission that is based upon information relating to any of the Holders furnished
in writing to the Company by any of the Holders.

    (b)  Each Holder of Transfer Restricted Securities agrees, severally and not
jointly, to indemnify and hold harmless the Company, and its directors and
officers, and each person, if any, who controls (within the meaning of
Section 15 of the Act or Section 20 of the Exchange Act) the Company, to the
same extent as the foregoing indemnity from the Company set forth in
section (a) above, but only with reference to information relating to such
Holder furnished in writing to the Company by such Holder expressly for use in
any Registration Statement. In no event shall any Holder, its directors,
officers or any Person who controls such Holder be liable or responsible for any
amount in excess of the amount by which the total amount received by such Holder
with respect to its sale of Transfer Restricted Securities pursuant to a
Registration Statement exceeds (i) the amount paid by such Holder for such
Transfer Restricted Securities and (ii) the amount of any damages that such
Holder, its directors, officers or any Person who controls such Holder has
otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission.

    (c)  In case any action shall be commenced involving any person in respect
of which indemnity may be sought pursuant to Section 8(a) or 8(b) (the
"INDEMNIFIED PARTY"), the indemnified party shall promptly notify the person
against whom such indemnity may be sought (the "INDEMNIFYING PERSON") in writing
and the indemnifying party shall assume the defense of such action, including
the employment of counsel reasonably satisfactory to the indemnified party and
the payment of all fees and expenses of such counsel, as incurred (except that
in the case of any action in respect of which indemnity may be sought pursuant
to both Sections 8(a) and 8(b), a Holder shall not be required to assume the
defense of such action pursuant to this Section 8(c), but may employ separate
counsel and participate in the defense thereof, but the fees and expenses of
such counsel, except as provided below, shall be at the expense of the Holder).
Any indemnified party shall have the right to employ separate counsel in any
such action and participate in the defense thereof, but the fees and expenses of
such counsel shall be at the expense of the indemnified party unless (i) the
employment of such counsel shall have been specifically authorized in writing by
the

                                       12
<PAGE>
indemnifying party, (ii) the indemnifying party shall have failed to assume the
defense of such action or employ counsel reasonably satisfactory to the
indemnified party or (iii) the named parties to any such action (including any
impleaded parties) include both the indemnified party and the indemnifying
party, and the indemnified party shall have been advised by such counsel that
there may be one or more legal defenses available to it which are different from
or additional to those available to the indemnifying party (in which case the
indemnifying party shall not have the right to assume the defense of such action
on behalf of the indemnified party). In any such case, the indemnifying party
shall not, in connection with any one action or separate but substantially
similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances, be liable for the fees and expenses of
more than one separate firm of attorneys (in addition to any local counsel) for
all indemnified parties and all such fees and expenses shall be reimbursed as
they are incurred. Such firm shall be designated in writing by a majority of the
Holders, in the case of the parties indemnified pursuant to Section 8(a), and by
the Company, in the case of parties indemnified pursuant to Section 8(b). The
indemnifying party shall indemnify and hold harmless the indemnified party from
and against any and all losses, claims, damages, liabilities and judgments by
reason of any settlement of any action (i) effected with its written consent or
(ii) effected without its written consent if the settlement is entered into more
than twenty business days after the indemnifying party shall have received a
request from the indemnified party for reimbursement for the fees and expenses
of counsel (in any case where such fees and expenses are at the expense of the
indemnifying party) and, prior to the date of such settlement, the indemnifying
party shall have failed to comply with such reimbursement request. No
indemnifying party shall, without the prior written consent of the indemnified
party, effect any settlement or compromise of, or consent to the entry of
judgment with respect to, any pending or threatened action in respect of which
the indemnified party is or could have been a party and indemnity or
contribution may be or could have been sought hereunder by the indemnified
party, unless such settlement, compromise or judgment (i) includes an
unconditional release of the indemnified party from all liability on claims that
are or could have been the subject matter of such action and (ii) does not
include a statement as to or an admission of fault, culpability or a failure to
act, by or on behalf of the indemnified party.

    (d)  To the extent that the indemnification provided for in this Section 8
is unavailable to an indemnified party in respect of any losses, claims,
damages, liabilities or judgments referred to therein, then each indemnifying
party, in lieu of indemnifying such indemnified party, shall contribute to the
amount paid or payable by such indemnified party as a result of such losses,
claims, damages, liabilities or judgments (i) in such proportion as is
appropriate to reflect the relative benefits received by the Company, on the one
hand, and the Holders, on the other hand, from their sale of Transfer Restricted
Securities or (ii) if the allocation provided by clause 8(d)(i) is not permitted
by applicable law, in such proportion as is appropriate to reflect not only the
relative benefits referred to in clause 8(d)(i) above but also the relative
fault of the Company, on the one hand, and of the Holder, on the other hand, in
connection with the statements or omissions which resulted in such losses,
claims, damages, liabilities or judgments, as well as any other relevant
equitable considerations. The relative fault of the Company, on the one hand,
and of the Holder, on the other hand, shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material fact
or the omission or alleged omission to state a material fact relates to
information supplied by the Company, on the one hand, or by the Holder, on the
other hand, and the parties' relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission. The amount
paid or payable by a party as a result of the losses, claims, damages,
liabilities and judgments referred to above shall be deemed to include, subject
to the limitations set forth in the second paragraph of Section 8(a), any legal
or other fees or expenses reasonably incurred by such party in connection with
investigating or defending any action or claim.

    The Company and each Holder agree that it would not be just and equitable if
contribution pursuant to this Section 8(d) were determined by pro rata
allocation (even if the Holders were treated as one entity for such purpose) or
by any other method of allocation which does not take account of the equitable
considerations referred to in the immediately preceding paragraph. The amount
paid or payable by an

                                       13
<PAGE>
indemnified party as a result of the losses, claims, damages, liabilities or
judgments referred to in the immediately preceding paragraph shall be deemed to
include, subject to the limitations set forth above, any legal or other expenses
reasonably incurred by such indemnified party in connection with investigating
or defending any matter, including any action that could have given rise to such
losses, claims, damages, liabilities or judgments. Notwithstanding the
provisions of this Section 8, no Holder, its directors, its officers or any
Person, if any, who controls such Holder shall be required to contribute, in the
aggregate, any amount in excess of the amount by which the total received by
such Holder with respect to the sale of Transfer Restricted Securities pursuant
to a Registration Statement exceeds (i) the amount paid by such Holder for such
Transfer Restricted Securities and (ii) the amount of any damages which such
Holder has otherwise been required to pay by reason of such untrue or alleged
untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Holders' obligations to contribute pursuant to this
Section 8(c) are several in proportion to the respective principal amount of
Transfer Restricted Securities held by each Holder hereunder and not joint.

9  RULE 144A AND RULE 144

    The Company agrees with each Holder, for so long as any Transfer Restricted
Securities remain outstanding and during any period in which the Company (i) is
not subject to Section 13 or 15(d) of the Exchange Act, to make available, upon
request of any Holder, to such Holder or beneficial owner of Transfer Restricted
Securities in connection with any sale thereof and any prospective purchaser of
such Transfer Restricted Securities designated by such Holder or beneficial
owner, the information required by Rule 144A(d)(4) under the Act in order to
permit resales of such Transfer Restricted Securities pursuant to Rule 144A, and
(ii) is subject to Section 13 or 15 (d) of the Exchange Act, to make all filings
required thereby in a timely manner in order to permit resales of such Transfer
Restricted Securities pursuant to Rule 144.

10  MISCELLANEOUS

    (a)  REMEDIES.  The Company acknowledges and agrees that any failure by the
Company to comply with its obligations under Sections 3 and 4 hereof may result
in material irreparable injury to the Initial Purchasers or the Holders for
which there is no adequate remedy at law, that it will not be possible to
measure damages for such injuries precisely and that, in the event of any such
failure, the Initial Purchasers or any Holder may obtain such relief as may be
required to specifically enforce the Company's obligations under Sections 3 and
4 hereof. The Company further agrees to waive the defense in any action for
specific performance that a remedy at law would be adequate.

    (b)  NO INCONSISTENT AGREEMENTS.  The Company will not, on or after the date
of this Agreement, enter into any agreement with respect to its securities that
is inconsistent with the rights granted to the Holders in this Agreement or
otherwise conflicts with the provisions hereof. The Company has not previously
entered into any agreement granting any registration rights with respect to its
securities to any Person except as disclosed in the Offering Memorandum, dated
as of July 18, 2000, with respect to the Series A Notes. The rights granted to
the Holders hereunder do not in any way conflict with and are not inconsistent
with the rights granted to the holders of the Company's securities under any
agreement in effect on the date hereof.

    (c)  AMENDMENTS AND WAIVERS.  The provisions of this Agreement may not be
amended, modified or supplemented, and waivers or consents to or departures from
the provisions hereof may not be given unless (i) in the case of Section 5
hereof and this Section 10(c)(i), the Company has obtained the written consent
of Holders of all outstanding Transfer Restricted Securities and (ii) in the
case of all other provisions hereof, the Company has obtained the written
consent of Holders of a majority of the outstanding principal amount of Transfer
Restricted Securities (excluding Transfer Restricted Securities

                                       14
<PAGE>
held by the Company or its Affiliates). Notwithstanding the foregoing, a waiver
or consent to departure from the provisions hereof that relates exclusively to
the rights of Holders whose Transfer Restricted Securities are being tendered
pursuant to the Exchange Offer, and that does not affect directly or indirectly
the rights of other Holders whose Transfer Restricted Securities are not being
tendered pursuant to such Exchange Offer, may be given by the Holders of a
majority of the outstanding principal amount of Transfer Restricted Securities
subject to such Exchange Offer.

    (d)  THIRD PARTY BENEFICIARY.  The Holders shall be third party
beneficiaries to the agreements made hereunder between the Company, on the one
hand, and the Initial Purchasers, on the other hand, and shall have the right to
enforce such agreements directly to the extent they may deem such enforcement
necessary or advisable to protect its rights or the rights of Holders hereunder.

    (e)  NOTICES.  All notices and other communications provided for or
permitted hereunder shall be made in writing by hand-delivery, first-class mail
(registered or certified, return receipt requested), telex, telecopier, or air
courier guaranteeing overnight delivery:

        (i)  if to a Holder, at the address set forth on the records of the
    Registrar under the Indenture, with a copy to the Registrar under the
    Indenture;

           With a copy to:

           Latham & Watkins
           885 Third Avenue
           New York, NY 10022
           Telecopier No.: (212) 751-4864
           Attention: Peter M. Labonski, Esq.

        (ii)  if to the Company:

           Nextel Partners, Inc.
           400 Carillon Point
           Kirkland, WA 98033
           Telecopier No.: (425) 828-8098
           Attention: Donald Manning, Esq.

           With copies to:

           Summit Law Group, PLLC
           1505 Westlake Avenue N., Suite 300
           Seattle, WA 98109
           Telecopier No.: (206) 281-9882
           Attention: Michael J. Erickson, Esq.

    All such notices and communications shall be deemed to have been duly given:
at the time delivered by hand, if personally delivered; five Business Days after
being deposited in the mail, postage prepaid, if mailed; when receipt
acknowledged, if telecopied; and on the next business day, if timely delivered
to an air courier guaranteeing overnight delivery.

    Copies of all such notices, demands or other communications shall be
concurrently delivered by the Person giving the same to the Trustee at the
address specified in the Indenture.

    Upon the date of filing of the Exchange Offer or a Shelf Registration
Statement, as the case may be, notice shall be delivered to Donaldson, Lufkin &
Jenrette Securities Corporation, (in the form attached hereto as Exhibit A) and
shall be addressed to: Attention: Louise Guarneri (Compliance Department), 277
Park Avenue, New York, New York 10172.

                                       15
<PAGE>
    (f)  SUCCESSORS AND ASSIGNS.  This Agreement shall inure to the benefit of
and be binding upon the successors and assigns of each of the parties, including
without limitation and without the need for an express assignment, subsequent
Holders; PROVIDED, that nothing herein shall be deemed to permit any assignment,
transfer or other disposition of Transfer Restricted Securities in violation of
the terms hereof or of the Purchase Agreement or the Indenture. If any
transferee of any Holder shall acquire Transfer Restricted Securities in any
manner, whether by operation of law or otherwise, such Transfer Restricted
Securities shall be held subject to all of the terms of this Agreement, and by
taking and holding such Transfer Restricted Securities such Person shall be
conclusively deemed to have agreed to be bound by and to perform all of the
terms and provisions of this Agreement, including the restrictions on resale set
forth in this Agreement and, if applicable, the Purchase Agreement, and such
Person shall be entitled to receive the benefits hereof.

    (g)  COUNTERPARTS.  This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

    (h)  HEADINGS.  The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

    (i)  GOVERNING LAW.  THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO THE
CONFLICT OF LAW RULES THEREOF.

    (j)  SEVERABILITY.  In the event that any one or more of the provisions
contained herein, or the application thereof in any circumstance, is held
invalid, illegal or unenforceable, the validity, legality and enforceability of
any such provision in every other respect and of the remaining provisions
contained herein shall not be affected or impaired thereby.

    (k)  ENTIRE AGREEMENT.  This Agreement is intended by the parties as a final
expression of their agreement and intended to be a complete and exclusive
statement of the agreement and understanding of the parties hereto in respect of
the subject matter contained herein. There are no restrictions, promises,
warranties or undertakings, other than those set forth or referred to herein
with respect to the registration rights granted with respect to the Transfer
Restricted Securities. This Agreement supersedes all prior agreements and
understandings between the parties with respect to such subject matter.

                                       16
<PAGE>
    IN WITNESS WHEREOF, the parties have executed this Agreement as of the date
first written above.

<TABLE>
<S>  <C>                                       <C>  <C>
                                               NEXTEL PARTNERS, INC.

                                               By:  ---------------------------------------
                                                    Name:
                                                    Title:

Donaldson, Lufkin & Jenrette Securities
Corporation
Deutsche Bank Securities
CIBC World Markets Corp.

By:  Donaldson, Lufkin & Jenrette Securities Corporation

By:  ---------------------------------------
     Name:
     Title:
</TABLE>

                  REGISTRATION RIGHTS AGREEMENT SIGNATURE PAGE

<PAGE>
                                   EXHIBIT A
                              NOTICE OF FILING OF
                   A/B EXCHANGE OFFER REGISTRATION STATEMENT

<TABLE>
<S>     <C>
 To:    Donaldson, Lufkin & Jenrette Securities Corporation
        277 Park Avenue
        New York, New York 10172
        Attention: Louise Guarneri (Compliance Department)
        Fax: (212) 892-7272

 From:  Nextel Partners, Inc.
        11% Senior Notes due 2010

 Date:  , 2000
</TABLE>

    For your information only (NO ACTION REQUIRED):

    Today,       , 2000, we filed [an A/B Exchange Registration Statement/a
Shelf Registration Statement] with the Securities and Exchange Commission. We
currently expect this registration statement to be declared effective within
business days of the date hereof.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00012-of-00352.parquet"}]]